US20180000355A1 - Assessing Cardiovascular Function Using an Optical Sensor - Google Patents

Assessing Cardiovascular Function Using an Optical Sensor Download PDF

Info

Publication number
US20180000355A1
US20180000355A1 US15/704,825 US201715704825A US2018000355A1 US 20180000355 A1 US20180000355 A1 US 20180000355A1 US 201715704825 A US201715704825 A US 201715704825A US 2018000355 A1 US2018000355 A1 US 2018000355A1
Authority
US
United States
Prior art keywords
blood
volume
blood volume
patient
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/704,825
Inventor
Brian Derek DeBusschere
Jeffrey L. Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Google LLC
Original Assignee
Google LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Google LLC filed Critical Google LLC
Priority to US15/704,825 priority Critical patent/US20180000355A1/en
Assigned to GOOGLE INC reassignment GOOGLE INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEBUSSCHERE, BRIAN DEREK, ROGERS, JEFFREY L.
Assigned to GOOGLE LLC reassignment GOOGLE LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GOOGLE INC.
Publication of US20180000355A1 publication Critical patent/US20180000355A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • A61B5/02108Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics
    • A61B5/02125Measuring pressure in heart or blood vessels from analysis of pulse wave characteristics of pulse wave propagation time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • A61B5/02427Details of sensor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/024Detecting, measuring or recording pulse rate or heart rate
    • A61B5/02416Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • A61B5/02427Details of sensor
    • A61B5/02433Details of sensor for infrared radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0261Measuring blood flow using optical means, e.g. infrared light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/1032Determining colour for diagnostic purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/1102Ballistocardiography

Definitions

  • Cardiovascular disease is the leading cause of morbidity and mortality worldwide. At the same time this chronic disease is largely preventable. Medical science knows how to save most of these lives by removing the major risk factors of smoking, diabetes, and hypertension. And many people are told just what they need to do to reduce these risk factors—stop smoking, reduce sugar intake, eat healthier, reduce alcohol intake, increase cardiovascular exercise, lose weight, and, if needed, take blood-pressure medication. But many people do not follow this good advice. Because of this, millions of people needlessly die from cardiovascular disease.
  • This document describes assessing cardiovascular function using an optical sensor, such as through sensing relevant hemodynamics understood by heart and respiration rates, heart rate variability, blood pressures, pulse-wave velocities, arterial stiffness, cardiac valve timing, ballistocardiogram force, photo-plethysmograms, blood oxygenation, and pressure-volume loops.
  • the techniques disclosed in this document use various optical sensors to sense the effects of cardiovascular hemodynamics, such as skin color or displacement at multiple spatial locations on the body. These optical sensors require little if any risk to the patient and are simple and easy for the patient to use.
  • the techniques described herein can determine blood flow asymmetries, which may indicate a stroke or other cardiovascular disease or pressure waveforms, which may indicate cardiac abnormalities, such as atrial fibrillation. These techniques may also determine trends in a patient's cardiovascular health. These trends can aid a patient by helping them know if the effort they are expending to improve their heart health is actually making a difference. Further, negative trends or conditions, such as cardiac irregularities or some asymmetries can be found that can spur people to improve their health or to get medical attention. By so doing, these techniques may save many people from dying of heart disease.
  • FIG. 1 illustrates an example environment in which the techniques can be implemented.
  • FIG. 2 illustrates an example computing device of FIG. 1 .
  • FIG. 3 illustrates an example optical sensor of FIG. 1 .
  • FIG. 4 illustrates a method for assessing cardiovascular function using an optical sensor, including determination of a pulse-wave velocity for a patient.
  • FIG. 5 illustrates a male patient having various regions of which images are captured by optical sensors.
  • FIG. 6 illustrates various circulatory distances that can be used, along with time correlations, to determine a pulse-wave velocity.
  • FIG. 7 illustrates a method for determining circulatory distances, such as those described in FIG. 6 .
  • FIG. 8 illustrates a method for assessing cardiovascular function using an optical sensor based on size, volume, or location of an organ or structure of a patient.
  • FIG. 9 illustrates an example device embodying, or in which techniques may be implemented that assess cardiovascular function using an optical sensor.
  • This document describes techniques using, and devices enabling, assessment of cardiovascular function using an optical sensor.
  • a patient's skin color and displacement over time can be accurately measured, including by comparing colors and displacements at different regions of the patient.
  • an optical sensor can measure a color change at a patient's cheek and, based on that color change, the techniques can determine that the patient's heart beat has produced a peak blood-pressure flow at some particular instant at the cheek.
  • Another optical sensor can measure a color change or displacement at the patient's wrist for the same heartbeat, which the techniques can determine indicates a peak blood-pressure flow at the wrist at some other instant. By comparing the times and distance between these regions, a pulse-wave velocity can be assessed.
  • This pulse-wave velocity can then be used to determine arterial stiffness, blood pressure, and other measurements of cardiovascular function. Simultaneously, those two measurement points can be used to independently measure other vitals like heart rate and respiration rate, with the combination of the two used to improve the measurement by compensating for movements, illumination changes, or occlusions.
  • the techniques may also measure trends in cardiovascular function.
  • a patient has an optical sensor in her bathroom that is capable of measuring color and displacement at multiple regions, such as her neck, palm, and forehead.
  • This optical sensor measures skin color variations between or within a region, which can indicate differential blood volume to provide a photo-plethysmogram (PPG).
  • PPG photo-plethysmogram
  • the techniques using data from the optical sensors, determine that her heart's stroke volume (an important measure of heart health) has improved 6% in four weeks. With this positive feedback, this patient may continue her diet and exercise routine, thereby likely reducing the chances that she will die of heart disease.
  • asymmetry in blood flow within a patient's face.
  • This asymmetry can be indicated to the patient or a medical professional sufficient to perform further testing, as asymmetry can indicate a stroke (a deadly disease that, with a fast diagnosis and treatment can save the patient's life or quality of life) or other vascular disease.
  • FIG. 1 is an illustration of an example environment 100 in which assessing cardiovascular function using an optical sensor can be employed.
  • Environment 100 illustrates a patient 102 that is a subject of the health monitoring, as well as a medical professional 104 , family member, or other caretaker that, in some cases, will receive results of the health monitoring.
  • This example employs optical sensors 106 , a color and displacement optical sensor 106 - 1 (sensor 106 - 1 ), which is part of computing device 108 , and a hyperspectral sensor 106 - 2 (sensor 106 - 2 ), which is located within mirror 110 .
  • Sensor data 112 is provided by each of optical sensors 106 to some computing device. As shown, sensor data 112 is passed from sensor 106 - 2 to computing device 108 while sensor 106 - 1 is integral with computing device 108 and need not be passed if the techniques are performed at that device. Computing device 108 then performs some or all of the techniques, or passes that sensor data to some other computing device, such as a remote server through a communication network (not shown).
  • a sensing milieu e.g., optical sensors 106 in patient 102 's bathroom
  • This sensing milieu is capable of non-invasively and remotely determining this cardiovascular function and trends in this cardiovascular function.
  • This sensing milieu senses various regions of the patient, which can then be compared, time correlated, aggregated, averaged, and so forth to determine a cardiovascular function.
  • These cardiovascular functions can be represented by cardiovascular asymmetries (e.g., due to a stoke), cardiac irregularities (e.g. atrial fibrillation), blood pressure, pulse-wave velocity, waveforms of circulating blood, photo-plethysmograms (PPG), ballistocardiograms, and pressure-volume loops, to name a few.
  • Computing device 108 can be one or a combination of various devices, here illustrated with seven examples: a smartphone 108 - 1 , a server 108 - 2 , a computing watch 108 - 3 , computing spectacles 108 - 4 , a laptop 108 - 5 , a tablet computer 108 - 6 , and a desktop 108 - 7 , though other computing devices and systems, such as a netbook or set-top box may also be used.
  • the techniques operate, in whole or in part, through a remote device such as server 108 - 2 .
  • some computing can be forgone locally, e.g., through a communication device having limited computing operations or even directly from optical sensors 106 to server 108 - 2 .
  • Computing device 108 includes or is able to communicate with a display 202 (six are shown in FIG. 2 ), a transceiver 204 , one or more processors 206 , and computer-readable storage media 208 (CRM 208 ).
  • Transceiver 204 is capable of sending and receiving data directly or through a communication network, such as sensor data 112 from optical sensors 106 through a local area, wide area, functional area, cellular, or near-field network.
  • CRM 208 includes cardiovascular-function module 210 , which includes or has access to sensor data 112 from one or more of multiple optical sensors 106 .
  • This sensor data 112 can be associated with particular times 212 , such that simultaneously received sensor data 112 can be correlated to determine cardiovascular functions 214 of human cardiovascular systems and trends 216 can be determined based on sensor data 112 changing over time.
  • CRM 208 also includes or has access to a user interface 218 , that, while not required, can be used to present determined trends, health, and medical advice to patient 102 .
  • cardiovascular-function module 210 is capable of determining, based on sensor data 112 , a cardiovascular function of a cardiovascular system of a patient, such as patient 102 of FIG. 1 . With this cardiovascular function, cardiovascular-function module 210 may alert patient 102 or medical professionals 104 or family members/caretakers of a negative health condition needing immediate care, for example. Medical professional 104 , or a specialized machine intelligence, could schedule an in-person appointment or remotely adjust patient care through changes in medication or lifestyle. Cardiovascular-function module 210 is also configured to determine trends based on the current cardiovascular function and prior-determined cardiovascular functions, such as those determined at prior times.
  • cardiovascular-function module 210 is capable of receiving and using optical sensor data indicating a skin, organ, or structure's color or displacement. This data may come from single or multiple optical sensors covering the same or different wavelengths observing multiple locations on the patient's body. With this data, cardiovascular-function module 210 can determine timing relationships, pulse pressure waveforms, and asymmetries in a patient's cardiovascular system. With this data and a circulatory distance between data from different regions of the patient, as well as time correlations between the data, cardiovascular-function module 210 can determine a pulse-wave velocity and various simple or highly sophisticated measures of cardiovascular function, including charts of blood pressure, a ballistocardiogram, a photo-plethysmogram (PPG), and pressure-volume loops. Capabilities of cardiovascular-function module 210 are addressed further in methods described below.
  • optical sensors 106 are capable of detecting blood volume, color, and/or displacement at one or more regions of a patient.
  • Optical sensors 106 may include a standard RGB (red, green, blue) sensor, a monochrome sensor, a hyperspectral sensor, a stereoscopic sensor, a structured light sensor, or combinations of multiple sensors, along with a combination of illumination sources such as uniform, infrared, tangential, modulated/coded, or coherent (laser).
  • Optical sensors 106 may also have a fixed camera position or consist of one or more cameras and light sources on mechanical targeting platforms or those that simply move due to being part of a mobile device. Optical sensors 106 may also be separated into physically and spatially distinct devices capable of monitoring the body from multiple view angles or observing different regions of the body. Thus, one of optical sensors 106 may capture an image indicating blood volume at two different regions of patient 102 , which then can be compared, by cardiovascular-function module 210 , to determine a blood-volume asymmetry or other cardiac function. In the case of a blood-volume asymmetry, a difference in vascular function between the regions may indicate a cardiac-related health problem, such as a stroke. Optical sensors 106 provide various types of information, and are not limited to determining asymmetries.
  • optical sensor 106 can be one or a combination of various devices, here illustrated with color and displacement optical sensor 106 - 1 (e.g., a camera of computing device 108 ), sensor 106 - 2 , which is stationary and located within mirror 110 , a wearable color and displacement optical sensor 106 - 3 , which is part of computing spectacles 108 - 4 , structured-light or stereoscopic sensor system 106 - 4 , and optic sensor 106 - 5 of laptop 108 - 5 .
  • the cameras can also be motorized to accurately point at specific points on the body.
  • sensor 106 - 2 is capable of capturing images in an ultraviolet, visible, or infrared optical wavelength. Images recording these wavelengths can be used to determine various changes in blood movement or as calibration signals to detect changes in illumination or patient movement. In some cases blood perfusion and oxygen content can be ascertained, thereby further enabling robust measurement of cardiac function. Due to differential wavelength absorption between human tissue and blood, a hyperspectral sensor can also be used to penetrate the skin to map out veins and arteries to target closer examination for displacement and other measurements.
  • Structured-light sensor system 106 - 4 is capable of projecting structured light at patient 102 and sensing, often with two or more optical sensors, the projected structured light on patient 102 effective to enable capture of images having surface information.
  • This surface information can be used to calculate depth and surface changes for a region of patient 102 , such as skin, another organ, or other structure. These changes can be highly accurate, thereby indicating small vibrations and other changes in an organ or structure caused by the cardiovascular system, and thus how that system is operating.
  • Structured-light sensor system 106 - 4 can, alternatively, be replaced with or supplemented with a targeted, coherent light source for more-accurate displacement measurements.
  • This may include LIDAR (e.g., “light radar” or the process measuring distance by illuminating a target with a laser and analyzing light reflected from the target), laser interferometry, or a process of analyzing light speckle patterns produced by a coherent light on a skin's surface through optical tracking, which enables detection of very small skin displacements.
  • LIDAR e.g., “light radar” or the process measuring distance by illuminating a target with a laser and analyzing light reflected from the target
  • laser interferometry or a process of analyzing light speckle patterns produced by a coherent light on a skin's surface through optical tracking, which enables detection of very small skin displacements.
  • These optical sensors 106 can capture images with sufficient resolution and at sufficient shutter speeds to show detailed colors and displacement, and thus enable determination of mechanical movements or vibrations. These mechanical movements and mechanical vibrations are sufficient to determine a ballistocardiogram (BCG) showing patient 102 's cardiac function.
  • BCG ballistocardiogram
  • Other sensing manners such as color change or skin displacement in a different region of a patient's body, can be used to establish motion frequency bands to amplify, as well as a timing reference for aggregating multiple heartbeat measurements to improve accuracy of a BCG motion.
  • This BCG information can also be used to provide reference timing information about when a blood pressure pulse leaves the left ventricle and enters the aorta, which combined with the other measurements across the body allows for more-precise estimates of pulse transit times and pulse-wave velocities.
  • the timing of the atrial valve can be monitored by tracking atrial pressure waveforms visible in the external or internal jugular. This also allows for the opportunity to detect atrial fibrillation by detecting missing atrial-pressure pulses. Additionally, aortic-wall stiffness has proven prognostic value in predicting cardiovascular morbidity and mortality. Measuring the pulse-transit time from the start of ejection from the left ventricle into the aorta and up the carotid allows an estimate of that aortic stiffness as well as trending of changes in that stiffness. Thus, determination of arterial-wall stiffness can made independent of blood pressure measurements.
  • optical sensors 106 are configured to capture sufficient information for the techniques to determine blood asymmetries and other cardiac function, including a pulse-wave velocity of patient 102 's blood.
  • This pulse-wave velocity is a measure of a patient's arterial health. In healthy arteries the pulse-wave velocity is low due to the elasticity of the arteries but, as they harden and narrow, the pulse-wave velocity rises. Additionally, as blood pressure increases and dilates the arteries, the walls become stiffer, increasing the pulse-wave velocity.
  • While a particular pulse-wave velocity as a snapshot in time may or may not accurately indicate cardiovascular health (e.g., a one-time test at a doctor's office), a change in this pulse-wave velocity (that is, a trend), can be an accurate measure of a change in patient 102 's cardiovascular health. If a positive trend, this can reinforce patient 102 's healthy habits and, if negative, encourage changes to be made.
  • each of the color-sensing optical sensors 106 is configured to record colors in a patient's skin sufficient to determine a photo-plethysmogram.
  • This PPG measures variations in a size or color of an organ, limb, or other human part from changes in an amount of blood present in or passing through it. These colors and color variations in a patient's skin can show heart rate and efficiency.
  • optical sensor 106 generally may have various computing capabilities, though it may instead be a low-capability device having little or no computing capability.
  • optical sensor 106 includes one or more computer processors 302 , computer-readable storage media 304 , image capture element 306 , and a wired or wireless transceiver 308 capable of receiving and transmitting information (e.g., to computing device 108 ).
  • Image capture element 306 may include simple or complex cameras, such as those having low or high shutter speeds, low or high frame rates, low or high resolutions, and having or not having non-visible imaging capabilities.
  • Computer-readable storage media 304 includes optics manager 310 , which is capable of processing sensor data and recording and transmitting sensor data, as well as receive or assign appropriate time markers by which to mark or compare the time of various captured images.
  • Optics manager 310 and cardiovascular-function module 210 may also calibrate image capture element 306 through use of an external sensor. This can aid in calibrating skin colors or displacements to a calibration color or displacement, or even to a cardiac function, such as to a blood pressure or pulse-wave velocity.
  • a blood pressure between those regions is also measured through a different device, thereby enabling more-accurate determination of cardiac functions for the optical sensor and for that patient.
  • Other potential calibration sensors include, but are not limited to, ECG, conventional BCG, digital stethoscopes, ultrasound, and the like.
  • ECG ECG
  • conventional BCG BCG
  • digital stethoscopes ultrasound
  • Another example is the use of an external blood pressure meter to calibrate the pulse wave velocity over time to determine long-term changes in arterial-wall stiffness by separating arterial stiffness due to blood pressure versus that due to the dilation by blood pressure.
  • FIGS. 1-3 act and interact
  • the environment 100 of FIG. 1 and the detailed illustrations of FIGS. 2 and 3 illustrate some of many possible environments capable of employing the described techniques.
  • FIGS. 4 and 8 depict methods that assess cardiovascular function using an optical sensor. These methods are shown as sets of blocks that specify operations performed but are not necessarily limited to the order or combinations shown for performing the operations by the respective blocks. In portions of the following discussion reference may be made to environment 100 of FIG. 1 and entities detailed in FIGS. 2 and 3 , reference to which is made for example only. The techniques are not limited to performance by one entity or multiple entities operating on one device.
  • skin colors or skin displacements are received from one or more optical sensors. These skin colors or displacements are captured at regions of a patient, such as a color captured at a patient's skin on her forehead and a displacement of skin on her neck or on her clavicle.
  • cardiovascular-function module 210 or optics manager 310 may automatically determine which regions of a patient are fully visible or partially occluded, and thereby determine better regions of a patient to capture images.
  • FIG. 5 shows a male patient 502 having various regions 504 of which images are captured.
  • regions 504 include, by way example, a cheek region 504 - 1 , a neck region 504 - 2 , an outer wrist region 504 - 3 , an outer hand region 504 - 4 , an inner wrist region 504 - 5 , a palm region 504 - 6 , a front ankle region 504 - 7 , and an inner ankle region 504 - 8 , to name but a few.
  • one optical sensor captures a color change or displacement of skin at neck region 504 - 2 and another color change or displacement of skin at inner wrist region 504 - 5 .
  • a circulatory distance is determined between the regions of the patient at which the colors or displacements are captured.
  • This circulatory distance can be an approximation based on a linear distance between the regions, such as a linear distance based on an axial distance oriented relative to an axis of the patient's spine, or simply a vertical distance with the patient standing.
  • the techniques determine or approximate a circulatory distance based on an arterial-path distance.
  • This arterial-path distance can be determined or approximated using an arterial structure of the patient or determined based on a skeletal structure of the patient, including automatically by optical visualization of the patient.
  • cardiovascular-function module 210 determines the circulatory distance from neck region 504 - 2 and inner wrist region 504 - 5 in one of the following four manners. In the first, a vertical distance D v is calculated with the patient standing.
  • an axial distance D axial is calculated based on the distance relative to an axis of the patient's spine—here it is similar to the vertical distance, D v , but if the person is oriented at an angle, the distances are different.
  • cardiovascular-function module 210 calculates the distance as a point-to-point between the regions, here shown as D ptp .
  • cardiovascular-function module 210 calculates or approximates the distance that blood travels through patient 502 's arteries, D path . This arterial-path distance can be determined based on the arteries themselves or an approximation based on a skeletal structure or an overall body shape of the person.
  • Data for skeletal structure and overall body shape can be determined using images captured for the regions and structures in between the regions, optically or otherwise.
  • radar can be used that penetrates clothing to track bony surfaces, thereby providing a skeletal structure from which arterial distance can be approximated.
  • operation 404 may be performed, in whole or in part, using method 700 illustrated in FIG. 7 , which is described following method 400 below.
  • the techniques determine one or more of the distances illustrated in FIG. 6 .
  • the more-accurate distance calculations provide a better pulse-wave velocity, and thus indicate a current cardiovascular function. While potentially valuable, more-accurate distances are not necessarily required to show trends in cardiovascular function. Trends are provided by consistently calculated distances more than accurate distances, and for a specific individual, should not change significantly over time for same measurement points. If the measurement points vary due to visibility issues (such as clothing), then distance measurement estimates increase in importance for accurate trending.
  • a time correlation between capture of the colors and displacements is determined. This time correlation is between the instant of capture at the regions, as this time correlation is later used. Cardiovascular-function module 210 may determine the time correlation based on a time at which a maximum or minimum blood volume is determined for each of the regions, or some other consistent and comparable point in a waveform, such as a beginning of a pressure increase in the waveform (show in FIG. 6 ). In more detail, this time correlation can be considered a temporal distance between multiple images capturing some measure of cardiac operation, such as blood volume at each of the regions. Thus, by comparing various images for a region cardiovascular-function module 210 can determine a maximum, minimum, or median color at the region as well as at another region, and by comparing these and times at which each were taken, can determine the time correlation for a same heartbeat.
  • waveforms 602 and 604 can be determined through color, or in some locations of the body, related waveforms can be determined through displacement.
  • Cardiovascular-function module 210 can determine, based on a change in color to regions over time, a waveform. These color changes indicate a peak or crest of a wave based on blood content at the organ and thus can be used to determine a shape of the wave. While a shape of a wave can differ at different regions, they can still be compared to find a time correlation. In the case of lower-than-desired optical frame rates due to sensitivity or processing limitations, interpolation or curve fitting can be used to improve the estimate of the waveform for improved time correlation.
  • a pulse-wave velocity for blood circulation through the patient is determined based on the circulatory distance and the time correlation, as well as the skin colors or displacements.
  • the time correlation is based on similar points in a waveform and the circulatory distance is some calculation or approximation of the distance blood travels from regions at which images are captured.
  • a pulse-wave velocity is the circulatory distance divided by the time correlation.
  • Pulse-wave velocity is a good measure of cardiac function. It can indicate, for example, an arterial stiffness of a patient (the faster the pulse-wave velocity, the higher the arterial stiffness), a blood pressure, and a mean arterial pressure for the patient.
  • the techniques can determine blood pressure based on the pulse-wave velocity using the Bramwell-Hill equation, which links pulse-wave velocity to compliance, blood mass density, and diastolic volume. Each of these are measures of cardiac function that can indicate a patient's cardiac health. As noted above, the techniques can provide these cardiac functions to a patient, thereby encouraging the patient to make changes or, in some cases, seek immediate medical care.
  • cardiovascular-function module 210 may determine which of the regions are superior to others, such as due to data captured for those regions being noisy or incomplete or otherwise of inferior quality. Those that are superior can be used and the others discarded, or cardiovascular-function module 210 may weigh the determined pulse wave velocity between different regions based on the quality of the data used to determine those pulse wave velocities. This can be performed prior to or after recording those pulse wave velocities as described below.
  • the techniques may proceed to record the pulse-wave velocity at operation 410 and the repeat operations 402 - 410 sufficient to determine a trend at operation 412 .
  • the determined pulse-wave velocity is provided, at operation 414 , to the patient or medical professional.
  • calibration data from an external sensor can be used to improve performance.
  • an external blood pressure monitor could be used to train the system to correlate PWV with blood pressure.
  • the device could be captured through an electronic network (BluetoothTM or the like) or the optical system could scan the user interface and perform OCR to read the results.
  • Machine learning could be applied to create a patient specific model for estimating blood pressure from PWV.
  • a cardiovascular trend for the patient is determined based on multiple pulse-wave velocity measurements, such as comparing prior and later-time determined pulse-wave velocities. This can simply show a trend of pulse-wave velocities rising or falling, such as with velocity rising due to increased arterial stiffness. Multiple locations across the body can be measured to map changes over time. Cardiovascular-function module 210 may also determine other measures of cardiac function, such as changes in flow asymmetries or pulse pressure waveforms over time.
  • this trend determined at operation 412 is provided to the patient or a medical professionals, e.g., patient 102 or 600 and medical professional 104 , of FIG. 1 or 6 .
  • skin color, skin displacement, or both are used by the techniques in method 400 .
  • color changes can indicate blood flow over time, as can displacement changes.
  • use of color and displacement both can indicate an amount of blood in capillaries in the skin while displacement can indicate a change to a volume of the skin or an organ under the skin, such as vein or artery, and thus an amount of blood in the skin or near it can be determined.
  • the techniques may repeat operations of method 400 for various other regions. Doing so may aid in altering the pulse-wave velocity to improve its accuracy or robustness by determining another pulse-wave velocity between two other regions or between another region and one of the regions for which images are captured.
  • the techniques may determine a pulse-wave velocity for the patient based on two pulse-wave velocities between regions, such as regions 504 - 3 and 504 - 1 , 504 - 7 and 504 - 1 , and/or 504 - 8 and 504 - 2 .
  • method 400 can be supplemented, and operation 404 may be performed, in whole or in part, using method 700 illustrated in FIG. 7 .
  • the techniques determine one or more of the distances illustrated in FIG. 6 .
  • operations 702 - 706 a patient's circulatory distances between regions are establish for later use as a manner in which to calibrate the patient's distances. While calibration for a single sensing milieu to determined trends may not be required, use of different sensing milieus or to determine a cardiovascular function with quantitative precision both aid from use of calibration.
  • Operation 708 and 710 can be used as one way in which the techniques may perform operation 404 of method 400 .
  • a distance between various regions is measured, optically, manually, or in other manners.
  • some physical data is available, such as a distance between the optical sensor capturing the image and patient 502 , or a height of patient 502 , and so forth. With this physical data, the distance can be determined from the image. Generally, this distance is from point-to-point, and is later analyzed for circulatory distance.
  • Other manners can also or instead be used, such as a nurse measuring patient 502 , either from point-to-point or along structures, such as from a wrist to an elbow, elbow to shoulder, and from shoulder to heart.
  • a patient may also interact with optical sensor 106 and cardiovascular-function module 210 to calibrate distances between regions, such as standing at a particular location relative to optical sensor 106 and so forth.
  • Various other technologies can be used as well, such as structured light optical sensors, radar, LIDAR, and SODAR (measuring distance through use of sound through air).
  • a circulatory distance is determined using the measured distance.
  • the measured distance is simply used as the circulatory distance, such as measuring D ptp and then using D ptp (of FIG. 6 ) as the circulatory distance.
  • other circulatory distances may be determined, such as measuring a point-to-point where patient 502 's arm is bent, and thus calculating a fully extended point-to-point to maintain consistency of circulatory distance.
  • Other examples include measuring D v and then, based on data about patient 502 , determining an arterial-path distance (D path ).
  • these various determined circulatory distances are associated with the patient's identity.
  • the identity of the patient can be entered, queried from the patient, or simply associated with some repeatable measure of identity, even if the person's name is not known. Examples include determining identity using fingerprints or facial recognition, and then associating distances with that fingerprint or facial structure.
  • the patient's identity is determined. This can be performed as part of operation 404 . With this identity, at 710 circulatory distances between regions are determined.
  • cardiovascular-function module 210 may use facial recognition to identify patient 502 and, after determining patient 502 's identity, find previously determined cardiovascular distances between each of regions 504 by simply mapping the relevant regions to previously stored distances.
  • a pulse wave velocity can be determined using the mapped-to cardiovascular distance for the regions measured.
  • FIG. 8 depicts a method for assessing cardiovascular function using an optical sensor based on size, volume, or location of an organ or structure of a patient.
  • images are captured over 2 to 10 millisecond-range or faster timeframes, thereby providing multiple images relating to an organ or structure of the patient. Note that sub-millisecond timeframes can also be useful for measure acoustic vibrations and are optional.
  • Method 800 may operate, in whole or in part, in conjunction with method 400 , though this is not required.
  • structured light is projected onto an organ or structure of a patient. Note that this is optional, though in some cases use of structured light aids in accurate measurement of movement and displacement of a region of the patient.
  • tangential light may be used to generate shadowing to detect skin displacement, or a coded light source could be used to reject external interference.
  • an alternating on and off light source at the frame rate would allow sampling and canceling of the background illumination.
  • light reflected from background objects or patient clothing can be used to track changes in lighting over time or in different conditions, e.g., daylight vs night, light bulb luminosity degradation over time, and so forth. With this data, ambient light and its effect on images captured can be calibrated and for which cardiovascular-function module 210 can adjust for the various methods described herein.
  • multiple images are received that capture an organ or structure of a patient.
  • the images captured may include capture of structured light to aid in determining displacement using surface information captured.
  • This surface information can be from one or multiple devices.
  • These multiple images can be received from one or multiple optical sensors and over various timeframes, such as those captured at millisecond-range or faster timeframes.
  • changes in the size, volume, or location of the organ or structure of the patient are determined. These changes are determined by comparing sizes, volumes, or locations of the organ or structure of the patient recorded by the various multiple images captured over time. Note that these changes can be used in coordination with, or to compensate for, data from methods 400 , and vice-versa. Thus, data from one portion of the body captured in any of the various manners described herein, can be used to compensate for other data, such as using a color or waveform determined at method 400 to compensate for motion artifacts in the data of method 800 .
  • a cardiac function of the patient is determined based on the changes.
  • This cardiac function can be one of the many described above, including heart rate, blood pressure, pulse-wave velocity, pressure volume loops, blood-volume and other asymmetries, and so forth, as well as respiration rate.
  • cardiovascular-function module 210 may compare the different cardiovascular pulse times of the regions, where one of the pulse times for a same heart beat is different, as it is further from the patient's heart.
  • the waveform's peak, median, or trough of blood volume can be accurately compared.
  • Cardiac function trends can greatly aid in helping patients maintain or change their habits to improve their cardiac health.
  • a trend showing a change to a cardiovascular function over weeks, months, or years using the techniques This trend can show cardiac function in many ways superior to the best invasive cardiac testing because a trend need not require perfect accuracy—instead consistency is used.
  • this can be performed by the techniques without interrupting the patient's day, making the patient perform a test, or requiring the patient to go see a medical professional. By so doing, many lives can be saved.
  • optical sensors 106 sense regions (e.g., regions 504 of FIG. 5 ) of a patient (e.g., patient 102 of FIG. 1 or patient 502 of FIGS. 5 and 6 ) through image capture elements 306 .
  • This sensor data e.g., images
  • optics manager 310 e.g., to mark the images with times
  • wired/wireless transceiver 308 as sensor data 112 to cardiovascular-function module 210 operating on computing device 108 of FIG. 2 .
  • indications of the region and the times 212 at which the sensor data 112 was captured are also passed.
  • Cardiovascular-function module 210 then performs operations of method 400 and/or method 800 to determine cardiac function, as noted above.
  • a safety threshold include a blood pressure being too high, a heart rate being too rapid or irregular, or a low blood-oxygen level.
  • This safety threshold can also be complicated or more difficult to determine, such as a patient's heart showing an end-diastolic volume ejected out of a ventricle during a contraction being less than 0.55 (this is a measure of ejection fraction (EF) and low fractions can indicate a heart attack is imminent).
  • EF ejection fraction
  • FIG. 9 illustrates various components of example computing system 900 that can be implemented as any type of client, server, and/or computing device as described with reference to the previous FIGS. 1-8 to implement techniques for assessing cardiovascular function using an optical sensor.
  • computing system 900 can be implemented as one or a combination of a wired and/or wireless wearable device, System-on-Chip (SoC), and/or as another type of device or portion thereof.
  • Computing system 900 may also be associated with a user (e.g., a patient) and/or an entity that operates the device such that a device describes logical devices that include users, software, firmware, and/or a combination of devices.
  • SoC System-on-Chip
  • Computing system 900 includes communication devices 902 that enable wired and/or wireless communication of device data 904 (e.g., received data, data that is being received, data scheduled for broadcast, data packets of the data, etc.).
  • Device data 904 or other device content can include configuration settings of the device, media content stored on the device, and/or information associated with a user of the device.
  • Media content stored on computing system 900 can include any type of audio, video, and/or image data, including complex or detailed results of cardiac function determination.
  • Computing system 900 includes one or more data inputs 906 via which any type of data, media content, and/or inputs can be received, such as human utterances, user-selectable inputs (explicit or implicit), messages, music, television media content, recorded video content, and any other type of audio, video, and/or image data received from any content and/or data source.
  • data inputs 906 via which any type of data, media content, and/or inputs can be received, such as human utterances, user-selectable inputs (explicit or implicit), messages, music, television media content, recorded video content, and any other type of audio, video, and/or image data received from any content and/or data source.
  • Computing system 900 also includes communication interfaces 908 , which can be implemented as any one or more of a serial and/or parallel interface, a wireless interface, any type of network interface, a modem, and as any other type of communication interface.
  • Communication interfaces 908 provide a connection and/or communication links between computing system 900 and a communication network by which other electronic, computing, and communication devices communicate data with computing system 900 .
  • Computing system 900 includes one or more processors 910 (e.g., any of microprocessors, controllers, and the like), which process various computer-executable instructions to control the operation of computing system 900 and to enable techniques for, or in which can be embodied, assessing cardiovascular function using an optical sensor.
  • processors 910 e.g., any of microprocessors, controllers, and the like
  • computing system 900 can be implemented with any one or combination of hardware, firmware, or fixed logic circuitry that is implemented in connection with processing and control circuits which are generally identified at 912 .
  • computing system 900 can include a system bus or data transfer system that couples the various components within the device.
  • a system bus can include any one or combination of different bus structures, such as a memory bus or memory controller, a peripheral bus, a universal serial bus, and/or a processor or local bus that utilizes any of a variety of bus architectures.
  • Computing system 900 also includes computer-readable media 914 , such as one or more memory devices that enable persistent and/or non-transitory data storage (i.e., in contrast to mere signal transmission), examples of which include random access memory (RAM), non-volatile memory (e.g., any one or more of a read-only memory (ROM), flash memory, EPROM, EEPROM, etc.), and a disk storage device.
  • RAM random access memory
  • non-volatile memory e.g., any one or more of a read-only memory (ROM), flash memory, EPROM, EEPROM, etc.
  • a disk storage device may be implemented as any type of magnetic or optical storage device, such as a hard disk drive, a recordable and/or rewriteable compact disc (CD), any type of a digital versatile disc (DVD), and the like.
  • Computing system 900 can also include a mass storage media device 916 .
  • Computer-readable media 914 provides data storage mechanisms to store device data 904 , as well as various device applications 918 and any other types of information and/or data related to operational aspects of computing system 900 .
  • an operating system 920 can be maintained as a computer application with computer-readable media 914 and executed on processors 910 .
  • Device applications 918 may include a device manager, such as any form of a control application, software application, signal-processing and control module, code that is native to a particular device, a hardware abstraction layer for a particular device, and so on.
  • Device applications 918 also include any system components, modules, or managers to implement the techniques.
  • device applications 918 include cardiovascular-function module 210 or optics manager 310 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Vascular Medicine (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

This document describes assessing cardiovascular function using an optical sensor, such as through sensing relevant hemodynamics understood by pulse transit times, blood pressures, pulse-wave velocities, and, in more breadth, ballistocardiograms and pressure-volume loops. The techniques disclosed in this document use various optical sensors to sense hemodynamics, such as skin color and skin and other organ displacement. These optical sensors require little if any risk to the patient and are simple and easy for the patient to use.

Description

    RELATED APPLICATIONS
  • This Application is a divisional of U.S. patent application Ser. No. 14/681,625, filed Apr. 8, 2015, entitled “Assessing Cardiovascular Function Using an Optical Sensor,” the entire disclosure of which is hereby incorporated by reference.
  • BACKGROUND
  • Cardiovascular disease is the leading cause of morbidity and mortality worldwide. At the same time this chronic disease is largely preventable. Medical science knows how to save most of these lives by removing the major risk factors of smoking, diabetes, and hypertension. And many people are told just what they need to do to reduce these risk factors—stop smoking, reduce sugar intake, eat healthier, reduce alcohol intake, increase cardiovascular exercise, lose weight, and, if needed, take blood-pressure medication. But many people do not follow this good advice. Because of this, millions of people needlessly die from cardiovascular disease.
  • People don't follow this good medical advice because they think they are different, they do not want to change their behaviors that are causing the disease, or they do not know what to change in their particular case. When a physician tells them that they are at risk from heart disease because they are overweight, for example, many people know that this judgment is not necessarily specific to them—it is based on averages and demographics. So being a particular weight may not negatively affect a particular patient's heart. Further, a lack of feedback that their behavior is harming their heart results in a lack of incentive for them to change their behavior.
  • This lack of incentive to follow good advice can be addressed by monitoring the state of the patient's cardiovascular system over time to show trends in heart health. Hard data often motivates patients to modify their behavior, such as data indicating that their heart shows measurable signs of heart disease. Unfortunately, current methods for measuring heart health can be inconvenient, stressful, and expensive. Simple home monitor products exist for measuring heart rate and blood pressure, but long-term user compliance is a problem due to inconvenience. More advanced cardiovascular monitoring, such as heart rate variability, arterial stiffness, cardiac output, and atrial fibrillation, involve expensive and time-consuming trips to a medical facility for a skilled assessment. Because of this, only patients that demonstrate late stage symptoms of heart disease are likely to receive these tests, which is generally too late to make simple lifestyle changes that would avoid a chronic disease.
  • Another reason that people don't follow this good advice, or don't follow it for long enough to prevent heart disease, is because they do not see the benefit. When people take the advice of changing their diet and habits—which most people do not want to do—they often don't see the improvement before they lose the motivation to continue monitoring their cardiovascular status. Because of this, many people go back to their old habits only to later die of heart disease.
  • SUMMARY
  • This document describes assessing cardiovascular function using an optical sensor, such as through sensing relevant hemodynamics understood by heart and respiration rates, heart rate variability, blood pressures, pulse-wave velocities, arterial stiffness, cardiac valve timing, ballistocardiogram force, photo-plethysmograms, blood oxygenation, and pressure-volume loops. The techniques disclosed in this document use various optical sensors to sense the effects of cardiovascular hemodynamics, such as skin color or displacement at multiple spatial locations on the body. These optical sensors require little if any risk to the patient and are simple and easy for the patient to use.
  • Further, the techniques described herein can determine blood flow asymmetries, which may indicate a stroke or other cardiovascular disease or pressure waveforms, which may indicate cardiac abnormalities, such as atrial fibrillation. These techniques may also determine trends in a patient's cardiovascular health. These trends can aid a patient by helping them know if the effort they are expending to improve their heart health is actually making a difference. Further, negative trends or conditions, such as cardiac irregularities or some asymmetries can be found that can spur people to improve their health or to get medical attention. By so doing, these techniques may save many people from dying of heart disease.
  • This summary is provided to introduce simplified concepts concerning the techniques, which are further described below in the Detailed Description. This summary is not intended to identify essential features of the claimed subject matter, nor is it intended for use in determining the scope of the claimed subject matter.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Embodiments of techniques and devices for assessing cardiovascular function using an optical sensor are described with reference to the following drawings. The same numbers are used throughout the drawings to reference like features and components:
  • FIG. 1 illustrates an example environment in which the techniques can be implemented.
  • FIG. 2 illustrates an example computing device of FIG. 1.
  • FIG. 3 illustrates an example optical sensor of FIG. 1.
  • FIG. 4 illustrates a method for assessing cardiovascular function using an optical sensor, including determination of a pulse-wave velocity for a patient.
  • FIG. 5 illustrates a male patient having various regions of which images are captured by optical sensors.
  • FIG. 6 illustrates various circulatory distances that can be used, along with time correlations, to determine a pulse-wave velocity.
  • FIG. 7 illustrates a method for determining circulatory distances, such as those described in FIG. 6.
  • FIG. 8 illustrates a method for assessing cardiovascular function using an optical sensor based on size, volume, or location of an organ or structure of a patient.
  • FIG. 9 illustrates an example device embodying, or in which techniques may be implemented that assess cardiovascular function using an optical sensor.
  • DETAILED DESCRIPTION Overview
  • This document describes techniques using, and devices enabling, assessment of cardiovascular function using an optical sensor. Through use of optical sensors a patient's skin color and displacement over time can be accurately measured, including by comparing colors and displacements at different regions of the patient. For example, an optical sensor can measure a color change at a patient's cheek and, based on that color change, the techniques can determine that the patient's heart beat has produced a peak blood-pressure flow at some particular instant at the cheek. Another optical sensor can measure a color change or displacement at the patient's wrist for the same heartbeat, which the techniques can determine indicates a peak blood-pressure flow at the wrist at some other instant. By comparing the times and distance between these regions, a pulse-wave velocity can be assessed. This pulse-wave velocity can then be used to determine arterial stiffness, blood pressure, and other measurements of cardiovascular function. Simultaneously, those two measurement points can be used to independently measure other vitals like heart rate and respiration rate, with the combination of the two used to improve the measurement by compensating for movements, illumination changes, or occlusions.
  • In addition to assessing cardiovascular heath at some snapshot in time, the techniques may also measure trends in cardiovascular function. By way of one example, assume that a patient has an optical sensor in her bathroom that is capable of measuring color and displacement at multiple regions, such as her neck, palm, and forehead. This optical sensor measures skin color variations between or within a region, which can indicate differential blood volume to provide a photo-plethysmogram (PPG). If the patient has other optical sensors, such as one in her computing spectacles and another in her smartphone, these can further aid the accuracy and robustness of the measurements. Using these sensors, assume that over the course of a new diet and exercise routine that the techniques, using data from the optical sensors, determine that her heart's stroke volume (an important measure of heart health) has improved 6% in four weeks. With this positive feedback, this patient may continue her diet and exercise routine, thereby likely reducing the chances that she will die of heart disease.
  • For another case, assume that the techniques determine that there is an asymmetry in blood flow within a patient's face. This asymmetry can be indicated to the patient or a medical professional sufficient to perform further testing, as asymmetry can indicate a stroke (a deadly disease that, with a fast diagnosis and treatment can save the patient's life or quality of life) or other vascular disease.
  • These are but a few examples in which assessing cardiovascular function using an optical sensor can be performed, other examples and details are provided below. This document now turns to an example environment, after which example optical sensors and methods, cardiovascular functions and trends, and an example computing system are described.
  • Example Environment
  • FIG. 1 is an illustration of an example environment 100 in which assessing cardiovascular function using an optical sensor can be employed. Environment 100 illustrates a patient 102 that is a subject of the health monitoring, as well as a medical professional 104, family member, or other caretaker that, in some cases, will receive results of the health monitoring. This example employs optical sensors 106, a color and displacement optical sensor 106-1 (sensor 106-1), which is part of computing device 108, and a hyperspectral sensor 106-2 (sensor 106-2), which is located within mirror 110.
  • Sensor data 112 is provided by each of optical sensors 106 to some computing device. As shown, sensor data 112 is passed from sensor 106-2 to computing device 108 while sensor 106-1 is integral with computing device 108 and need not be passed if the techniques are performed at that device. Computing device 108 then performs some or all of the techniques, or passes that sensor data to some other computing device, such as a remote server through a communication network (not shown).
  • As shown with this example environment 100, a sensing milieu (e.g., optical sensors 106 in patient 102's bathroom) in which a patient lives can be used that are capable of determining a cardiovascular function of a human cardiovascular system. This sensing milieu is capable of non-invasively and remotely determining this cardiovascular function and trends in this cardiovascular function. This sensing milieu senses various regions of the patient, which can then be compared, time correlated, aggregated, averaged, and so forth to determine a cardiovascular function. These cardiovascular functions can be represented by cardiovascular asymmetries (e.g., due to a stoke), cardiac irregularities (e.g. atrial fibrillation), blood pressure, pulse-wave velocity, waveforms of circulating blood, photo-plethysmograms (PPG), ballistocardiograms, and pressure-volume loops, to name a few.
  • With regard to the example computing device 108 of FIG. 1, consider a detailed illustration in FIG. 2. Computing device 108 can be one or a combination of various devices, here illustrated with seven examples: a smartphone 108-1, a server 108-2, a computing watch 108-3, computing spectacles 108-4, a laptop 108-5, a tablet computer 108-6, and a desktop 108-7, though other computing devices and systems, such as a netbook or set-top box may also be used. As noted above, in some embodiments the techniques operate, in whole or in part, through a remote device such as server 108-2. In such cases, some computing can be forgone locally, e.g., through a communication device having limited computing operations or even directly from optical sensors 106 to server 108-2.
  • Computing device 108 includes or is able to communicate with a display 202 (six are shown in FIG. 2), a transceiver 204, one or more processors 206, and computer-readable storage media 208 (CRM 208). Transceiver 204 is capable of sending and receiving data directly or through a communication network, such as sensor data 112 from optical sensors 106 through a local area, wide area, functional area, cellular, or near-field network.
  • CRM 208 includes cardiovascular-function module 210, which includes or has access to sensor data 112 from one or more of multiple optical sensors 106. This sensor data 112 can be associated with particular times 212, such that simultaneously received sensor data 112 can be correlated to determine cardiovascular functions 214 of human cardiovascular systems and trends 216 can be determined based on sensor data 112 changing over time. CRM 208 also includes or has access to a user interface 218, that, while not required, can be used to present determined trends, health, and medical advice to patient 102.
  • Generally, cardiovascular-function module 210 is capable of determining, based on sensor data 112, a cardiovascular function of a cardiovascular system of a patient, such as patient 102 of FIG. 1. With this cardiovascular function, cardiovascular-function module 210 may alert patient 102 or medical professionals 104 or family members/caretakers of a negative health condition needing immediate care, for example. Medical professional 104, or a specialized machine intelligence, could schedule an in-person appointment or remotely adjust patient care through changes in medication or lifestyle. Cardiovascular-function module 210 is also configured to determine trends based on the current cardiovascular function and prior-determined cardiovascular functions, such as those determined at prior times.
  • More specifically, cardiovascular-function module 210 is capable of receiving and using optical sensor data indicating a skin, organ, or structure's color or displacement. This data may come from single or multiple optical sensors covering the same or different wavelengths observing multiple locations on the patient's body. With this data, cardiovascular-function module 210 can determine timing relationships, pulse pressure waveforms, and asymmetries in a patient's cardiovascular system. With this data and a circulatory distance between data from different regions of the patient, as well as time correlations between the data, cardiovascular-function module 210 can determine a pulse-wave velocity and various simple or highly sophisticated measures of cardiovascular function, including charts of blood pressure, a ballistocardiogram, a photo-plethysmogram (PPG), and pressure-volume loops. Capabilities of cardiovascular-function module 210 are addressed further in methods described below.
  • With regard to optical sensors 106, two examples of which are shown in FIG. 1, consider a detailed illustration in FIG. 3. Generally, optical sensors 106 are capable of detecting blood volume, color, and/or displacement at one or more regions of a patient. Optical sensors 106 may include a standard RGB (red, green, blue) sensor, a monochrome sensor, a hyperspectral sensor, a stereoscopic sensor, a structured light sensor, or combinations of multiple sensors, along with a combination of illumination sources such as uniform, infrared, tangential, modulated/coded, or coherent (laser). Optical sensors 106 may also have a fixed camera position or consist of one or more cameras and light sources on mechanical targeting platforms or those that simply move due to being part of a mobile device. Optical sensors 106 may also be separated into physically and spatially distinct devices capable of monitoring the body from multiple view angles or observing different regions of the body. Thus, one of optical sensors 106 may capture an image indicating blood volume at two different regions of patient 102, which then can be compared, by cardiovascular-function module 210, to determine a blood-volume asymmetry or other cardiac function. In the case of a blood-volume asymmetry, a difference in vascular function between the regions may indicate a cardiac-related health problem, such as a stroke. Optical sensors 106 provide various types of information, and are not limited to determining asymmetries.
  • In more detail, optical sensor 106 can be one or a combination of various devices, here illustrated with color and displacement optical sensor 106-1 (e.g., a camera of computing device 108), sensor 106-2, which is stationary and located within mirror 110, a wearable color and displacement optical sensor 106-3, which is part of computing spectacles 108-4, structured-light or stereoscopic sensor system 106-4, and optic sensor 106-5 of laptop 108-5. The cameras can also be motorized to accurately point at specific points on the body.
  • As noted in part, sensor 106-2 is capable of capturing images in an ultraviolet, visible, or infrared optical wavelength. Images recording these wavelengths can be used to determine various changes in blood movement or as calibration signals to detect changes in illumination or patient movement. In some cases blood perfusion and oxygen content can be ascertained, thereby further enabling robust measurement of cardiac function. Due to differential wavelength absorption between human tissue and blood, a hyperspectral sensor can also be used to penetrate the skin to map out veins and arteries to target closer examination for displacement and other measurements.
  • Structured-light sensor system 106-4 is capable of projecting structured light at patient 102 and sensing, often with two or more optical sensors, the projected structured light on patient 102 effective to enable capture of images having surface information. This surface information can be used to calculate depth and surface changes for a region of patient 102, such as skin, another organ, or other structure. These changes can be highly accurate, thereby indicating small vibrations and other changes in an organ or structure caused by the cardiovascular system, and thus how that system is operating. Structured-light sensor system 106-4 can, alternatively, be replaced with or supplemented with a targeted, coherent light source for more-accurate displacement measurements. This may include LIDAR (e.g., “light radar” or the process measuring distance by illuminating a target with a laser and analyzing light reflected from the target), laser interferometry, or a process of analyzing light speckle patterns produced by a coherent light on a skin's surface through optical tracking, which enables detection of very small skin displacements.
  • These optical sensors 106 can capture images with sufficient resolution and at sufficient shutter speeds to show detailed colors and displacement, and thus enable determination of mechanical movements or vibrations. These mechanical movements and mechanical vibrations are sufficient to determine a ballistocardiogram (BCG) showing patient 102's cardiac function. Other sensing manners, such as color change or skin displacement in a different region of a patient's body, can be used to establish motion frequency bands to amplify, as well as a timing reference for aggregating multiple heartbeat measurements to improve accuracy of a BCG motion. This BCG information can also be used to provide reference timing information about when a blood pressure pulse leaves the left ventricle and enters the aorta, which combined with the other measurements across the body allows for more-precise estimates of pulse transit times and pulse-wave velocities.
  • While the BCG signal indicates the timing of the aortic valve, the timing of the atrial valve can be monitored by tracking atrial pressure waveforms visible in the external or internal jugular. This also allows for the opportunity to detect atrial fibrillation by detecting missing atrial-pressure pulses. Additionally, aortic-wall stiffness has proven prognostic value in predicting cardiovascular morbidity and mortality. Measuring the pulse-transit time from the start of ejection from the left ventricle into the aorta and up the carotid allows an estimate of that aortic stiffness as well as trending of changes in that stiffness. Thus, determination of arterial-wall stiffness can made independent of blood pressure measurements.
  • In more detail, optical sensors 106 are configured to capture sufficient information for the techniques to determine blood asymmetries and other cardiac function, including a pulse-wave velocity of patient 102's blood. This pulse-wave velocity is a measure of a patient's arterial health. In healthy arteries the pulse-wave velocity is low due to the elasticity of the arteries but, as they harden and narrow, the pulse-wave velocity rises. Additionally, as blood pressure increases and dilates the arteries, the walls become stiffer, increasing the pulse-wave velocity. While a particular pulse-wave velocity as a snapshot in time may or may not accurately indicate cardiovascular health (e.g., a one-time test at a doctor's office), a change in this pulse-wave velocity (that is, a trend), can be an accurate measure of a change in patient 102's cardiovascular health. If a positive trend, this can reinforce patient 102's healthy habits and, if negative, encourage changes to be made.
  • In more detail, each of the color-sensing optical sensors 106 is configured to record colors in a patient's skin sufficient to determine a photo-plethysmogram. This PPG measures variations in a size or color of an organ, limb, or other human part from changes in an amount of blood present in or passing through it. These colors and color variations in a patient's skin can show heart rate and efficiency.
  • These examples show some ways in which the techniques can provide substantially more-valuable (or at least different) data by which to assess a patient's cardiac function than those provided in a medical office or hospital. As noted, conventional health monitoring is often performed at a hospital or medical practitioner's office. Health monitoring at a hospital or office, however, cannot monitor a patient during their normal course of life or as often as desired. This can be a serious limitation because a snapshot captured at a hospital or office may not accurately reflect the patient's health or may not performed at all due to the infrequency of a patient's visits. Even if testing at a hospital or medical office is performed often, it can be inaccurate due to it being of a short duration or due to the testing being in an artificial environment. Note that this does not preclude the use of the techniques disclosed herein at a hospital or medical office, where they may prove valuable in supplementing or replacing conventional measurements, and in the case of in-patient care, may provide a manner for continuous monitoring of patients that are critically (or otherwise) ill.
  • Returning to FIG. 3, optical sensor 106 generally may have various computing capabilities, though it may instead be a low-capability device having little or no computing capability. Here optical sensor 106 includes one or more computer processors 302, computer-readable storage media 304, image capture element 306, and a wired or wireless transceiver 308 capable of receiving and transmitting information (e.g., to computing device 108). Image capture element 306 may include simple or complex cameras, such as those having low or high shutter speeds, low or high frame rates, low or high resolutions, and having or not having non-visible imaging capabilities. Computer-readable storage media 304 includes optics manager 310, which is capable of processing sensor data and recording and transmitting sensor data, as well as receive or assign appropriate time markers by which to mark or compare the time of various captured images. Optics manager 310 and cardiovascular-function module 210 may also calibrate image capture element 306 through use of an external sensor. This can aid in calibrating skin colors or displacements to a calibration color or displacement, or even to a cardiac function, such as to a blood pressure or pulse-wave velocity. Thus, while one of optical sensors 106 captures images for two regions, a blood pressure between those regions is also measured through a different device, thereby enabling more-accurate determination of cardiac functions for the optical sensor and for that patient. Other potential calibration sensors include, but are not limited to, ECG, conventional BCG, digital stethoscopes, ultrasound, and the like. Another example is the use of an external blood pressure meter to calibrate the pulse wave velocity over time to determine long-term changes in arterial-wall stiffness by separating arterial stiffness due to blood pressure versus that due to the dilation by blood pressure.
  • These and other capabilities, as well as ways in which entities of FIGS. 1-3 act and interact, are set forth in greater detail below. These entities may be further divided, combined, and so on. The environment 100 of FIG. 1 and the detailed illustrations of FIGS. 2 and 3 illustrate some of many possible environments capable of employing the described techniques.
  • Example Methods
  • FIGS. 4 and 8 depict methods that assess cardiovascular function using an optical sensor. These methods are shown as sets of blocks that specify operations performed but are not necessarily limited to the order or combinations shown for performing the operations by the respective blocks. In portions of the following discussion reference may be made to environment 100 of FIG. 1 and entities detailed in FIGS. 2 and 3, reference to which is made for example only. The techniques are not limited to performance by one entity or multiple entities operating on one device.
  • At 402, skin colors or skin displacements are received from one or more optical sensors. These skin colors or displacements are captured at regions of a patient, such as a color captured at a patient's skin on her forehead and a displacement of skin on her neck or on her clavicle. Optionally, as part of operation 402, cardiovascular-function module 210 or optics manager 310 may automatically determine which regions of a patient are fully visible or partially occluded, and thereby determine better regions of a patient to capture images.
  • By way of illustration, consider FIG. 5, which shows a male patient 502 having various regions 504 of which images are captured. These regions 504 include, by way example, a cheek region 504-1, a neck region 504-2, an outer wrist region 504-3, an outer hand region 504-4, an inner wrist region 504-5, a palm region 504-6, a front ankle region 504-7, and an inner ankle region 504-8, to name but a few. By way of an ongoing example, assume that one optical sensor captures a color change or displacement of skin at neck region 504-2 and another color change or displacement of skin at inner wrist region 504-5.
  • At 404, a circulatory distance is determined between the regions of the patient at which the colors or displacements are captured. This circulatory distance can be an approximation based on a linear distance between the regions, such as a linear distance based on an axial distance oriented relative to an axis of the patient's spine, or simply a vertical distance with the patient standing. In some cases, however, the techniques determine or approximate a circulatory distance based on an arterial-path distance. This arterial-path distance can be determined or approximated using an arterial structure of the patient or determined based on a skeletal structure of the patient, including automatically by optical visualization of the patient.
  • By way of illustration of the various circulatory distances that can be used, consider FIG. 6. Here assume that multiple images are captured of patient 502's neck region 504-2 (also shown in FIG. 5) sufficient to determine a neck waveform 602. Multiple images are also captured of inner wrist region 504-5 sufficient to determine an inner-wrist waveform 604. At operation 404, cardiovascular-function module 210 determines the circulatory distance from neck region 504-2 and inner wrist region 504-5 in one of the following four manners. In the first, a vertical distance Dv is calculated with the patient standing. In the second, an axial distance Daxial is calculated based on the distance relative to an axis of the patient's spine—here it is similar to the vertical distance, Dv, but if the person is oriented at an angle, the distances are different. In the third, cardiovascular-function module 210 calculates the distance as a point-to-point between the regions, here shown as Dptp. In the fourth, cardiovascular-function module 210 calculates or approximates the distance that blood travels through patient 502's arteries, Dpath. This arterial-path distance can be determined based on the arteries themselves or an approximation based on a skeletal structure or an overall body shape of the person. Data for skeletal structure and overall body shape can be determined using images captured for the regions and structures in between the regions, optically or otherwise. In some cases radar can be used that penetrates clothing to track bony surfaces, thereby providing a skeletal structure from which arterial distance can be approximated.
  • While not required, operation 404 may be performed, in whole or in part, using method 700 illustrated in FIG. 7, which is described following method 400 below. By way of overview, in this example method, the techniques determine one or more of the distances illustrated in FIG. 6.
  • The more-accurate distance calculations provide a better pulse-wave velocity, and thus indicate a current cardiovascular function. While potentially valuable, more-accurate distances are not necessarily required to show trends in cardiovascular function. Trends are provided by consistently calculated distances more than accurate distances, and for a specific individual, should not change significantly over time for same measurement points. If the measurement points vary due to visibility issues (such as clothing), then distance measurement estimates increase in importance for accurate trending.
  • At 406, a time correlation between capture of the colors and displacements is determined. This time correlation is between the instant of capture at the regions, as this time correlation is later used. Cardiovascular-function module 210 may determine the time correlation based on a time at which a maximum or minimum blood volume is determined for each of the regions, or some other consistent and comparable point in a waveform, such as a beginning of a pressure increase in the waveform (show in FIG. 6). In more detail, this time correlation can be considered a temporal distance between multiple images capturing some measure of cardiac operation, such as blood volume at each of the regions. Thus, by comparing various images for a region cardiovascular-function module 210 can determine a maximum, minimum, or median color at the region as well as at another region, and by comparing these and times at which each were taken, can determine the time correlation for a same heartbeat.
  • Note that waveforms 602 and 604 can be determined through color, or in some locations of the body, related waveforms can be determined through displacement. Cardiovascular-function module 210 can determine, based on a change in color to regions over time, a waveform. These color changes indicate a peak or crest of a wave based on blood content at the organ and thus can be used to determine a shape of the wave. While a shape of a wave can differ at different regions, they can still be compared to find a time correlation. In the case of lower-than-desired optical frame rates due to sensitivity or processing limitations, interpolation or curve fitting can be used to improve the estimate of the waveform for improved time correlation. Repeated measurements, which are time shifted relative to the pressure wave either naturally by the optical sampling frequency or intentionally by adjusting the sampling frequency, can build up a super-sampled estimate of the waveform. The higher timing-resolution waveform can be used for more-accurate timing measurements. Additionally, displacements, either through direct distance measurements or tangential shading, can show signals related to the pressure waveforms as the arteries and veins expand and contract. These waveforms can further reveal cardiac activity, such as valve timing, valve leakage (regurgitation), fibrillation, stroke volume, and the like.
  • At 408, a pulse-wave velocity for blood circulation through the patient is determined based on the circulatory distance and the time correlation, as well as the skin colors or displacements. As shown in FIG. 6, the time correlation is based on similar points in a waveform and the circulatory distance is some calculation or approximation of the distance blood travels from regions at which images are captured. In more detail, a pulse-wave velocity is the circulatory distance divided by the time correlation.
  • Pulse-wave velocity is a good measure of cardiac function. It can indicate, for example, an arterial stiffness of a patient (the faster the pulse-wave velocity, the higher the arterial stiffness), a blood pressure, and a mean arterial pressure for the patient. In more detail, the techniques can determine blood pressure based on the pulse-wave velocity using the Bramwell-Hill equation, which links pulse-wave velocity to compliance, blood mass density, and diastolic volume. Each of these are measures of cardiac function that can indicate a patient's cardiac health. As noted above, the techniques can provide these cardiac functions to a patient, thereby encouraging the patient to make changes or, in some cases, seek immediate medical care.
  • Note that, in some cases, three or more different regions are measured at operation 402. In these cases, cardiovascular-function module 210 may determine which of the regions are superior to others, such as due to data captured for those regions being noisy or incomplete or otherwise of inferior quality. Those that are superior can be used and the others discarded, or cardiovascular-function module 210 may weigh the determined pulse wave velocity between different regions based on the quality of the data used to determine those pulse wave velocities. This can be performed prior to or after recording those pulse wave velocities as described below.
  • Following determination of the pulse-wave velocity at operation 408, the techniques may proceed to record the pulse-wave velocity at operation 410 and the repeat operations 402-410 sufficient to determine a trend at operation 412. In some cases, however, the determined pulse-wave velocity is provided, at operation 414, to the patient or medical professional. Optionally, calibration data from an external sensor can be used to improve performance. For example, an external blood pressure monitor could be used to train the system to correlate PWV with blood pressure. The device could be captured through an electronic network (Bluetooth™ or the like) or the optical system could scan the user interface and perform OCR to read the results. Machine learning could be applied to create a patient specific model for estimating blood pressure from PWV.
  • At 412, a cardiovascular trend for the patient is determined based on multiple pulse-wave velocity measurements, such as comparing prior and later-time determined pulse-wave velocities. This can simply show a trend of pulse-wave velocities rising or falling, such as with velocity rising due to increased arterial stiffness. Multiple locations across the body can be measured to map changes over time. Cardiovascular-function module 210 may also determine other measures of cardiac function, such as changes in flow asymmetries or pulse pressure waveforms over time.
  • At 414, as noted, this trend determined at operation 412, or a pulse-wave velocity determined at operation 408, is provided to the patient or a medical professionals, e.g., patient 102 or 600 and medical professional 104, of FIG. 1 or 6.
  • In some cases skin color, skin displacement, or both are used by the techniques in method 400. Thus, color changes can indicate blood flow over time, as can displacement changes. Furthermore, use of color and displacement both can indicate an amount of blood in capillaries in the skin while displacement can indicate a change to a volume of the skin or an organ under the skin, such as vein or artery, and thus an amount of blood in the skin or near it can be determined.
  • Note also that the techniques may repeat operations of method 400 for various other regions. Doing so may aid in altering the pulse-wave velocity to improve its accuracy or robustness by determining another pulse-wave velocity between two other regions or between another region and one of the regions for which images are captured. Thus, the techniques may determine a pulse-wave velocity for the patient based on two pulse-wave velocities between regions, such as regions 504-3 and 504-1, 504-7 and 504-1, and/or 504-8 and 504-2.
  • As noted above, method 400 can be supplemented, and operation 404 may be performed, in whole or in part, using method 700 illustrated in FIG. 7. In this example method, the techniques determine one or more of the distances illustrated in FIG. 6. For operations 702-706, a patient's circulatory distances between regions are establish for later use as a manner in which to calibrate the patient's distances. While calibration for a single sensing milieu to determined trends may not be required, use of different sensing milieus or to determine a cardiovascular function with quantitative precision both aid from use of calibration. Operation 708 and 710 can be used as one way in which the techniques may perform operation 404 of method 400.
  • At 702, a distance between various regions is measured, optically, manually, or in other manners. Consider, for example, capturing an image of patient 502 of FIG. 5. Assume that some physical data is available, such as a distance between the optical sensor capturing the image and patient 502, or a height of patient 502, and so forth. With this physical data, the distance can be determined from the image. Generally, this distance is from point-to-point, and is later analyzed for circulatory distance. Other manners can also or instead be used, such as a nurse measuring patient 502, either from point-to-point or along structures, such as from a wrist to an elbow, elbow to shoulder, and from shoulder to heart. A patient may also interact with optical sensor 106 and cardiovascular-function module 210 to calibrate distances between regions, such as standing at a particular location relative to optical sensor 106 and so forth. Various other technologies can be used as well, such as structured light optical sensors, radar, LIDAR, and SODAR (measuring distance through use of sound through air).
  • At 704, a circulatory distance is determined using the measured distance. In some cases the measured distance is simply used as the circulatory distance, such as measuring Dptp and then using Dptp (of FIG. 6) as the circulatory distance. As noted in part herein, however, other circulatory distances may be determined, such as measuring a point-to-point where patient 502's arm is bent, and thus calculating a fully extended point-to-point to maintain consistency of circulatory distance. Other examples include measuring Dv and then, based on data about patient 502, determining an arterial-path distance (Dpath).
  • At 706, these various determined circulatory distances are associated with the patient's identity. The identity of the patient can be entered, queried from the patient, or simply associated with some repeatable measure of identity, even if the person's name is not known. Examples include determining identity using fingerprints or facial recognition, and then associating distances with that fingerprint or facial structure.
  • At 708, the patient's identity is determined. This can be performed as part of operation 404. With this identity, at 710 circulatory distances between regions are determined. For example, cardiovascular-function module 210 may use facial recognition to identify patient 502 and, after determining patient 502's identity, find previously determined cardiovascular distances between each of regions 504 by simply mapping the relevant regions to previously stored distances. When cardiovascular time correlations are determined at operation 406, a pulse wave velocity can be determined using the mapped-to cardiovascular distance for the regions measured.
  • FIG. 8 depicts a method for assessing cardiovascular function using an optical sensor based on size, volume, or location of an organ or structure of a patient. In method 800, images are captured over 2 to 10 millisecond-range or faster timeframes, thereby providing multiple images relating to an organ or structure of the patient. Note that sub-millisecond timeframes can also be useful for measure acoustic vibrations and are optional. Method 800 may operate, in whole or in part, in conjunction with method 400, though this is not required.
  • At 802, structured light is projected onto an organ or structure of a patient. Note that this is optional, though in some cases use of structured light aids in accurate measurement of movement and displacement of a region of the patient. Alternatively, tangential light may be used to generate shadowing to detect skin displacement, or a coded light source could be used to reject external interference. For example, an alternating on and off light source at the frame rate would allow sampling and canceling of the background illumination. Further, light reflected from background objects or patient clothing can be used to track changes in lighting over time or in different conditions, e.g., daylight vs night, light bulb luminosity degradation over time, and so forth. With this data, ambient light and its effect on images captured can be calibrated and for which cardiovascular-function module 210 can adjust for the various methods described herein.
  • At 804, multiple images are received that capture an organ or structure of a patient. As noted, the images captured may include capture of structured light to aid in determining displacement using surface information captured. This surface information can be from one or multiple devices. These multiple images can be received from one or multiple optical sensors and over various timeframes, such as those captured at millisecond-range or faster timeframes.
  • At 806, changes in the size, volume, or location of the organ or structure of the patient are determined. These changes are determined by comparing sizes, volumes, or locations of the organ or structure of the patient recorded by the various multiple images captured over time. Note that these changes can be used in coordination with, or to compensate for, data from methods 400, and vice-versa. Thus, data from one portion of the body captured in any of the various manners described herein, can be used to compensate for other data, such as using a color or waveform determined at method 400 to compensate for motion artifacts in the data of method 800.
  • At 808, a cardiac function of the patient is determined based on the changes. This cardiac function can be one of the many described above, including heart rate, blood pressure, pulse-wave velocity, pressure volume loops, blood-volume and other asymmetries, and so forth, as well as respiration rate.
  • By way of a first example, consider a case where an asymmetry is determined between to different regions of the patient. In some cases this asymmetry is determined by blood-volume differences, which can be indicated by size or color. To determine an asymmetry, cardiovascular-function module 210 may compare the different cardiovascular pulse times of the regions, where one of the pulse times for a same heart beat is different, as it is further from the patient's heart. Alternatively, the waveform's peak, median, or trough of blood volume can be accurately compared. Thus, assume that a right wrist and a left wrist of a patient have different blood volumes at each of their peaks, with one being a lower peak blood volume that the other, thereby indicating some difference in vascular function.
  • Cardiac function trends, as noted in part above, can greatly aid in helping patients maintain or change their habits to improve their cardiac health. Consider, for example, a trend showing a change to a cardiovascular function over weeks, months, or years using the techniques. This trend can show cardiac function in many ways superior to the best invasive cardiac testing because a trend need not require perfect accuracy—instead consistency is used. Furthermore, this can be performed by the techniques without interrupting the patient's day, making the patient perform a test, or requiring the patient to go see a medical professional. By so doing, many lives can be saved.
  • In more detail, consider the techniques in the context of FIGS. 1-3. Here various kinds of optical sensors 106 sense regions (e.g., regions 504 of FIG. 5) of a patient (e.g., patient 102 of FIG. 1 or patient 502 of FIGS. 5 and 6) through image capture elements 306. This sensor data (e.g., images) are then processed and/or stored by optics manager 310 (e.g., to mark the images with times), after which they are passed, through wired/wireless transceiver 308 as sensor data 112 to cardiovascular-function module 210 operating on computing device 108 of FIG. 2. Also passed are indications of the region and the times 212 at which the sensor data 112 was captured.
  • Cardiovascular-function module 210 then performs operations of method 400 and/or method 800 to determine cardiac function, as noted above. Consider, for example, a case where cardiovascular-function module 210 determines that a cardiac function meets or exceeds a safety threshold. Example safety thresholds include a blood pressure being too high, a heart rate being too rapid or irregular, or a low blood-oxygen level. This safety threshold can also be complicated or more difficult to determine, such as a patient's heart showing an end-diastolic volume ejected out of a ventricle during a contraction being less than 0.55 (this is a measure of ejection fraction (EF) and low fractions can indicate a heart attack is imminent). These are but a few of the many safety thresholds for cardiac function enabled by the techniques. If a safety threshold is exceeded, medical professional 104 (or family/caretaker) and patient 102 can be informed, such by operation 810 of method 800.
  • The preceding discussion describes methods relating to assessing cardiovascular function using an optical sensor for a human cardiovascular system. Aspects of these methods may be implemented in hardware (e.g., fixed logic circuitry), firmware, software, manual processing, or any combination thereof. These techniques may be embodied on one or more of the entities shown in FIGS. 1-3 and 9 (computing system 900 is described in FIG. 9 below), which may be further divided, combined, and so on. Thus, these figures illustrate some of the many possible systems or apparatuses capable of employing the described techniques. The entities of these figures generally represent software, firmware, hardware, whole devices or networks, or a combination thereof.
  • Example Computing System
  • FIG. 9 illustrates various components of example computing system 900 that can be implemented as any type of client, server, and/or computing device as described with reference to the previous FIGS. 1-8 to implement techniques for assessing cardiovascular function using an optical sensor. In embodiments, computing system 900 can be implemented as one or a combination of a wired and/or wireless wearable device, System-on-Chip (SoC), and/or as another type of device or portion thereof. Computing system 900 may also be associated with a user (e.g., a patient) and/or an entity that operates the device such that a device describes logical devices that include users, software, firmware, and/or a combination of devices.
  • Computing system 900 includes communication devices 902 that enable wired and/or wireless communication of device data 904 (e.g., received data, data that is being received, data scheduled for broadcast, data packets of the data, etc.). Device data 904 or other device content can include configuration settings of the device, media content stored on the device, and/or information associated with a user of the device. Media content stored on computing system 900 can include any type of audio, video, and/or image data, including complex or detailed results of cardiac function determination. Computing system 900 includes one or more data inputs 906 via which any type of data, media content, and/or inputs can be received, such as human utterances, user-selectable inputs (explicit or implicit), messages, music, television media content, recorded video content, and any other type of audio, video, and/or image data received from any content and/or data source.
  • Computing system 900 also includes communication interfaces 908, which can be implemented as any one or more of a serial and/or parallel interface, a wireless interface, any type of network interface, a modem, and as any other type of communication interface. Communication interfaces 908 provide a connection and/or communication links between computing system 900 and a communication network by which other electronic, computing, and communication devices communicate data with computing system 900.
  • Computing system 900 includes one or more processors 910 (e.g., any of microprocessors, controllers, and the like), which process various computer-executable instructions to control the operation of computing system 900 and to enable techniques for, or in which can be embodied, assessing cardiovascular function using an optical sensor. Alternatively or in addition, computing system 900 can be implemented with any one or combination of hardware, firmware, or fixed logic circuitry that is implemented in connection with processing and control circuits which are generally identified at 912. Although not shown, computing system 900 can include a system bus or data transfer system that couples the various components within the device. A system bus can include any one or combination of different bus structures, such as a memory bus or memory controller, a peripheral bus, a universal serial bus, and/or a processor or local bus that utilizes any of a variety of bus architectures.
  • Computing system 900 also includes computer-readable media 914, such as one or more memory devices that enable persistent and/or non-transitory data storage (i.e., in contrast to mere signal transmission), examples of which include random access memory (RAM), non-volatile memory (e.g., any one or more of a read-only memory (ROM), flash memory, EPROM, EEPROM, etc.), and a disk storage device. A disk storage device may be implemented as any type of magnetic or optical storage device, such as a hard disk drive, a recordable and/or rewriteable compact disc (CD), any type of a digital versatile disc (DVD), and the like. Computing system 900 can also include a mass storage media device 916.
  • Computer-readable media 914 provides data storage mechanisms to store device data 904, as well as various device applications 918 and any other types of information and/or data related to operational aspects of computing system 900. For example, an operating system 920 can be maintained as a computer application with computer-readable media 914 and executed on processors 910. Device applications 918 may include a device manager, such as any form of a control application, software application, signal-processing and control module, code that is native to a particular device, a hardware abstraction layer for a particular device, and so on.
  • Device applications 918 also include any system components, modules, or managers to implement the techniques. In this example, device applications 918 include cardiovascular-function module 210 or optics manager 310.
  • CONCLUSION
  • Although embodiments of techniques for, and apparatuses enabling, assessing cardiovascular function using an optical sensor have been described in language specific to features and/or methods, it is to be understood that the subject of the appended claims is not necessarily limited to the specific features or methods described. Rather, the specific features and methods are disclosed as example implementations of these techniques.

Claims (20)

What is claimed is:
1. A computer-implemented method comprising:
receiving, from an optical sensor capable of detecting blood volume at two or more regions of a patient, an image indicating a first blood volume for a first region and another image indicating a second blood volume for a second region;
comparing the first blood volume for the first region and the second blood volume for the second region to provide a blood-volume asymmetry; and
determining, based on the blood-volume asymmetry, a difference in vascular function between the first region and the second region.
2. The method of claim 1, wherein determining the difference in vascular function is based on the comparing the first and second blood volumes indicating a lower peak blood volume at one of the first or second blood volumes than the other of the first or second blood volumes.
3. The method of claim 1, further comprising indicating, to the patient or a medical professional associated with the patient, a potential stroke or other vascular disease based on the difference in vascular function.
4. The method of claim 1, wherein the image and the other image indicate the first blood volume and the second blood volume with skin colors and further comprising determining the first blood volume and the second blood volume using the skin colors of the first and second regions, respectively.
5. The method of claim 1, wherein the image and the other image indicate the first blood volume and the second blood volume with skin displacements and further comprising determining the first blood volume and the second blood volume using the skin displacements of the first and second regions, respectively.
6. The method of claim 1, further comprising calibrating the optical sensor with one or more external sensors effective to calibrate the first blood volume and the second blood volume to a calibration blood-volume asymmetry, the calibrating prior to determining the blood-volume asymmetry, and wherein providing the blood-volume asymmetry is based at least in part on the calibration.
7. A system comprising:
an optical sensor capable of detecting blood volume at two or more regions of a patient;
a computer processor; and
one or more computer-readable storage media having instructions stored thereon that, responsive to execution by the computer processor, performs operations comprising:
receiving, from the optical sensor, an image indicating a first blood volume for a first region and another image indicating a second blood volume for a second region;
comparing the first blood volume for the first region and the second blood volume for the second region to provide a blood-volume asymmetry; and
determining, based on the blood-volume asymmetry, a difference in vascular function between the first region and the second region.
8. The system of claim 7, wherein determining the difference in vascular function is based on the comparing the first and second blood volumes indicating a lower peak blood volume at one of the first or second blood volumes than the other of the first or second blood volumes.
9. The system of claim 7, the operations further comprising indicating, to the patient or a medical professional associated with the patient, a potential stroke or other vascular disease based on the difference in vascular function.
10. The system of claim 7, wherein the image and the other image indicate the first blood volume and the second blood volume with skin colors and the operations further comprise determining the first blood volume and the second blood volume using the skin colors of the first and second regions, respectively.
11. The system of claim 7, wherein the image and the other image indicate the first blood volume and the second blood volume with skin displacements and the operations further comprise determining the first blood volume and the second blood volume using the skin displacements of the first and second regions, respectively.
12. The system of claim 7, the operations further comprising calibrating the one or more optical sensors with one or more external sensors effective to calibrate the first blood volume and the second blood volume to a calibration blood-volume asymmetry, the calibrating prior to determining the blood-volume asymmetry, and wherein providing the blood-volume asymmetry is based at least in part on the calibration.
13. The system of claim 7, the operations further comprising:
performing the operations again at a later time to determine a later-time difference in vascular function; and
determining a cardiac trend for the patient based on the later-time vascular difference and the vascular difference.
14. One or more computer-readable storage media having instructions stored thereon that, responsive to execution by a computer processor, performs operations comprising:
receiving, from an optical sensor capable of detecting blood volume at two or more regions of a patient, an image indicating a first blood volume for a first region and another image indicating a second blood volume for a second region;
comparing the first blood volume for the first region and the second blood volume for the second region to provide a blood-volume asymmetry; and
determining, based on the blood-volume asymmetry, a difference in vascular function between the first region and the second region.
15. The media of claim 14, wherein determining the difference in vascular function is based on the comparing the first and second blood volumes indicating a lower peak blood volume at one of the first or second blood volumes than the other of the first or second blood volumes.
16. The media of claim 14, wherein the instructions further perform operations comprising indicating, to the patient or a medical professional associated with the patient, a potential stroke or other vascular disease based on the difference in vascular function.
17. The media of claim 14, wherein the image and the other image indicate the first blood volume and the second blood volume with skin colors and the instructions further perform operations comprising determining the first blood volume and the second blood volume using the skin colors of the first and second regions, respectively.
18. The media of claim 14, wherein the image and the other image indicate the first blood volume and the second blood volume with skin displacements and the instructions further perform operations comprising determining the first blood volume and the second blood volume using the skin displacements of the first and second regions, respectively.
19. The media of claim 14, wherein the instructions further perform operations comprising calibrating the one or more optical sensors with one or more external sensors effective to calibrate the first blood volume and the second blood volume to a calibration blood-volume asymmetry, the calibrating prior to determining the blood-volume asymmetry, and wherein providing the blood-volume asymmetry is based at least in part on the calibration.
20. The media of claim 14, wherein the instructions further perform operations comprising:
performing the operations again at a later time to determine a later-time difference in vascular function; and
determining a cardiac trend for the patient based on the later-time vascular difference and the vascular difference.
US15/704,825 2015-04-08 2017-09-14 Assessing Cardiovascular Function Using an Optical Sensor Abandoned US20180000355A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/704,825 US20180000355A1 (en) 2015-04-08 2017-09-14 Assessing Cardiovascular Function Using an Optical Sensor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/681,625 US9848780B1 (en) 2015-04-08 2015-04-08 Assessing cardiovascular function using an optical sensor
US15/704,825 US20180000355A1 (en) 2015-04-08 2017-09-14 Assessing Cardiovascular Function Using an Optical Sensor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14/681,625 Division US9848780B1 (en) 2015-04-08 2015-04-08 Assessing cardiovascular function using an optical sensor

Publications (1)

Publication Number Publication Date
US20180000355A1 true US20180000355A1 (en) 2018-01-04

Family

ID=57217849

Family Applications (3)

Application Number Title Priority Date Filing Date
US14/681,625 Active US9848780B1 (en) 2015-04-08 2015-04-08 Assessing cardiovascular function using an optical sensor
US15/704,615 Abandoned US20180000354A1 (en) 2015-04-08 2017-09-14 Assessing Cardiovascular Function Using an Optical Sensor
US15/704,825 Abandoned US20180000355A1 (en) 2015-04-08 2017-09-14 Assessing Cardiovascular Function Using an Optical Sensor

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US14/681,625 Active US9848780B1 (en) 2015-04-08 2015-04-08 Assessing cardiovascular function using an optical sensor
US15/704,615 Abandoned US20180000354A1 (en) 2015-04-08 2017-09-14 Assessing Cardiovascular Function Using an Optical Sensor

Country Status (4)

Country Link
US (3) US9848780B1 (en)
EP (1) EP3280324A4 (en)
CN (1) CN107427237B (en)
WO (1) WO2016178797A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016162B1 (en) 2015-03-23 2018-07-10 Google Llc In-ear health monitoring
US10064582B2 (en) 2015-01-19 2018-09-04 Google Llc Noninvasive determination of cardiac health and other functional states and trends for human physiological systems
US10080528B2 (en) 2015-05-19 2018-09-25 Google Llc Optical central venous pressure measurement
US10310621B1 (en) 2015-10-06 2019-06-04 Google Llc Radar gesture sensing using existing data protocols
US10376195B1 (en) 2015-06-04 2019-08-13 Google Llc Automated nursing assessment
US10409385B2 (en) 2014-08-22 2019-09-10 Google Llc Occluded gesture recognition
US10496182B2 (en) 2015-04-30 2019-12-03 Google Llc Type-agnostic RF signal representations
US10642367B2 (en) 2014-08-07 2020-05-05 Google Llc Radar-based gesture sensing and data transmission
US10664059B2 (en) 2014-10-02 2020-05-26 Google Llc Non-line-of-sight radar-based gesture recognition
US10664061B2 (en) 2015-04-30 2020-05-26 Google Llc Wide-field radar-based gesture recognition
US10817070B2 (en) 2015-04-30 2020-10-27 Google Llc RF-based micro-motion tracking for gesture tracking and recognition
US10936085B2 (en) 2015-05-27 2021-03-02 Google Llc Gesture detection and interactions
US10948996B2 (en) 2014-06-03 2021-03-16 Google Llc Radar-based gesture-recognition at a surface of an object
US11140787B2 (en) 2016-05-03 2021-10-05 Google Llc Connecting an electronic component to an interactive textile
US11169988B2 (en) 2014-08-22 2021-11-09 Google Llc Radar recognition-aided search

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9848780B1 (en) 2015-04-08 2017-12-26 Google Inc. Assessing cardiovascular function using an optical sensor
US10791938B2 (en) 2015-06-14 2020-10-06 Facense Ltd. Smartglasses for detecting congestive heart failure
US11103139B2 (en) 2015-06-14 2021-08-31 Facense Ltd. Detecting fever from video images and a baseline
US11064892B2 (en) 2015-06-14 2021-07-20 Facense Ltd. Detecting a transient ischemic attack using photoplethysmogram signals
US10799122B2 (en) 2015-06-14 2020-10-13 Facense Ltd. Utilizing correlations between PPG signals and iPPG signals to improve detection of physiological responses
US10667697B2 (en) 2015-06-14 2020-06-02 Facense Ltd. Identification of posture-related syncope using head-mounted sensors
US10349887B1 (en) 2015-06-14 2019-07-16 Facense Ltd. Blood pressure measuring smartglasses
US11154203B2 (en) 2015-06-14 2021-10-26 Facense Ltd. Detecting fever from images and temperatures
US10376163B1 (en) 2015-06-14 2019-08-13 Facense Ltd. Blood pressure from inward-facing head-mounted cameras
US11103140B2 (en) 2015-06-14 2021-08-31 Facense Ltd. Monitoring blood sugar level with a comfortable head-mounted device
US10638938B1 (en) 2015-06-14 2020-05-05 Facense Ltd. Eyeglasses to detect abnormal medical events including stroke and migraine
CN109558000B (en) * 2017-09-26 2021-01-22 京东方科技集团股份有限公司 Man-machine interaction method and electronic equipment
EP3503114A1 (en) 2017-12-22 2019-06-26 Koninklijke Philips N.V. Apparatus and method for detecting an ongoing ischemic stroke in a subject or detecting whether a subject is at risk of developing an ischemic stroke
WO2018131021A2 (en) * 2018-04-16 2018-07-19 Universidad De Panamá Mirror device for viewing the diagnosis of people through scanning of the eye and of the palm of the hand
EP3566641A1 (en) * 2018-05-08 2019-11-13 Koninklijke Philips N.V. Apparatus for determining a blood pressure measurement
US10424035B1 (en) * 2018-05-16 2019-09-24 Trungram Gyaltrul R. Sherpa Monitoring conditions associated with remote individuals over a data communication network and automatically notifying responsive to detecting customized emergency conditions
CN108852307B (en) * 2018-05-24 2020-11-24 重庆理工大学 Non-contact non-invasive arteriosclerosis detection device
CN109009051A (en) * 2018-06-26 2018-12-18 广州视源电子科技股份有限公司 heart rate measuring method, device, equipment and storage medium
US20210015991A1 (en) 2018-10-19 2021-01-21 PatenSee Ltd. Systems and methods for monitoring the functionality of a blood vessel
US11779222B2 (en) 2019-07-10 2023-10-10 Compal Electronics, Inc. Method of and imaging system for clinical sign detection
EP4316365A1 (en) * 2022-08-02 2024-02-07 Nokia Technologies Oy Determining velocity from speckle images

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036685A1 (en) * 2000-04-27 2003-02-20 Vitalsines International, Inc. Physiological signal monitoring system
US20080039731A1 (en) * 2005-08-22 2008-02-14 Massachusetts Institute Of Technology Wearable Pulse Wave Velocity Blood Pressure Sensor and Methods of Calibration Thereof
US20090299197A1 (en) * 2008-06-02 2009-12-03 Antonelli Lynn T Remote Blood Pressure Waveform Sensing Method and Apparatus
US20160045706A1 (en) * 2013-04-10 2016-02-18 Koninklijke Philips N.V. System and method for enhancing sleep slow wave activity based on cardiac activity
US20160089042A1 (en) * 2014-09-29 2016-03-31 Microsoft Corporation Wearable pulse pressure wave sensing device

Family Cites Families (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4986277A (en) 1988-08-24 1991-01-22 Sackner Marvin A Method and apparatus for non-invasive monitoring of central venous pressure
EP0467853B1 (en) * 1990-07-18 1996-01-10 AVL Medical Instruments AG Device and method for the measurement of blood pressure
US5121124A (en) 1991-05-01 1992-06-09 Thermo Electron Technologies Corp. Microwave camera
JP3144030B2 (en) 1992-02-24 2001-03-07 東陶機器株式会社 Health management network system
US5517251A (en) 1994-04-28 1996-05-14 The Regents Of The University Of California Acquisition of video images simultaneously with analog signals
US5959529A (en) 1997-03-07 1999-09-28 Kail, Iv; Karl A. Reprogrammable remote sensor monitoring system
EP1304555B1 (en) 1997-07-16 2007-05-23 Terumo Kabushiki Kaisha Ear type clinical thermometer
JP2982792B2 (en) 1998-05-22 1999-11-29 セイコーエプソン株式会社 Method for manufacturing thin film transistor
DE69934508T2 (en) 1998-10-20 2007-09-27 Omron Healthcare Co., Ltd. INFRARED THERMOMETER
US6313825B1 (en) 1998-12-28 2001-11-06 Gateway, Inc. Virtual input device
JP2000333910A (en) 1999-05-25 2000-12-05 Nippon Colin Co Ltd Cardiac function monitoring device
WO2001027855A2 (en) 1999-10-12 2001-04-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention Image-synchronized multichannel biomedical data acquisition system
US6524239B1 (en) 1999-11-05 2003-02-25 Wcr Company Apparatus for non-instrusively measuring health parameters of a subject and method of use thereof
US7194371B1 (en) 2000-03-27 2007-03-20 Cardiobeat.Com Medical testing system and method
WO2002008941A1 (en) 2000-07-20 2002-01-31 Marchosky J Alexander Patient-controlled automated medical record, diagnosis, and treatment system and method
WO2002082999A1 (en) 2001-04-10 2002-10-24 Battelle Memorial Institute Image analysis system and method for discriminating movements of an individual
WO2003034300A2 (en) 2001-09-04 2003-04-24 Ramon Van Der Riet Marketing communication and transaction/distribution services platform for building and managing personalized customer relationships
AUPS335302A0 (en) 2002-07-03 2002-07-25 Uscom Pty Ltd Intergrated pressure and volume measurement method and apparatus
US8190239B2 (en) 2002-09-03 2012-05-29 Fujitsu Limited Individual identification device
US20090177068A1 (en) 2002-10-09 2009-07-09 Stivoric John M Method and apparatus for providing derived glucose information utilizing physiological and/or contextual parameters
US20080065291A1 (en) 2002-11-04 2008-03-13 Automotive Technologies International, Inc. Gesture-Based Control of Vehicular Components
US20040249250A1 (en) 2003-06-04 2004-12-09 Mcgee Michael D. System and apparatus for monitoring and prompting medical self-care events and communicating medical self-care status
CN100435723C (en) 2003-08-20 2008-11-26 纽卡迪奥公司 Apparatus and method for cordless recording and telecommunication transmission of three special ecg leads
DE102004004604B4 (en) 2004-01-29 2016-12-29 Siemens Healthcare Gmbh Method and imaging system for compensating patient motion during continuous shooting in medical imaging
WO2006006159A1 (en) 2004-07-09 2006-01-19 Aerotel Medical Systems (1998) Ltd. A wearable device, system and method for monitoring physiological and/or environmental parameters
US8560972B2 (en) 2004-08-10 2013-10-15 Microsoft Corporation Surface UI for gesture-based interaction
US7942744B2 (en) 2004-08-19 2011-05-17 Igt Virtual input system
EP1835845A4 (en) * 2004-12-28 2008-09-10 Hypermed Inc Hyperspectral/multispectral imaging in determination, assessment and monitoring of systemic physiology and shock
US7733224B2 (en) 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
US20070118043A1 (en) 2005-11-23 2007-05-24 Microsoft Corporation Algorithms for computing heart rate and movement speed of a user from sensor data
US7317416B2 (en) 2005-12-22 2008-01-08 Leonard Flom Skeletal topography imaging radar for unique individual identification
US20070161921A1 (en) 2006-01-07 2007-07-12 Rausch Jeffrey L Bio-accurate temperature measurement device and method of quantitatively normalizing a body temperature measurement to determine a physiologically significant temperature event
DE102006018445B4 (en) 2006-04-18 2008-04-24 Imedos Gmbh Apparatus and method for determining arterio-venous ratio values by quantitative analysis of retinal vessels
US9814425B2 (en) 2006-05-12 2017-11-14 Koninklijke Philips N.V. Health monitoring appliance
US7558622B2 (en) 2006-05-24 2009-07-07 Bao Tran Mesh network stroke monitoring appliance
WO2007143535A2 (en) 2006-06-01 2007-12-13 Biancamed Ltd. Apparatus, system, and method for monitoring physiological signs
US7691067B2 (en) 2006-06-14 2010-04-06 Advanced Brain Monitoring, Inc. Method for measuring central venous pressure or respiratory effort
US10437459B2 (en) 2007-01-07 2019-10-08 Apple Inc. Multitouch data fusion
US8607167B2 (en) 2007-01-07 2013-12-10 Apple Inc. Portable multifunction device, method, and graphical user interface for providing maps and directions
US20090017910A1 (en) 2007-06-22 2009-01-15 Broadcom Corporation Position and motion tracking of an object
US7846104B2 (en) 2007-02-08 2010-12-07 Heart Force Medical Inc. Monitoring physiological condition and detecting abnormalities
US8918153B2 (en) 2007-02-16 2014-12-23 Mespere Lifesciences Inc. Method and device for measuring parameters of cardiac function
US8639309B2 (en) 2007-07-31 2014-01-28 J&M Shuler, Inc. Method and system for monitoring oxygenation levels of compartments and tissue
WO2008140780A1 (en) 2007-05-10 2008-11-20 Grigore Burdea Periodic evaluation and telerehabilitation systems and methods
US20080294012A1 (en) 2007-05-22 2008-11-27 Kurtz Andrew F Monitoring physiological conditions
US8302033B2 (en) 2007-06-22 2012-10-30 Apple Inc. Touch screen device, method, and graphical user interface for providing maps, directions, and location-based information
JP5060186B2 (en) 2007-07-05 2012-10-31 株式会社東芝 Pulse wave processing apparatus and method
WO2009032073A1 (en) 2007-08-28 2009-03-12 Woolsthorpe, Llc Non-invasive method and system for determining physiological characteristics
US20090058820A1 (en) 2007-09-04 2009-03-05 Microsoft Corporation Flick-based in situ search from ink, text, or an empty selection region
WO2009036329A1 (en) 2007-09-14 2009-03-19 Corventis, Inc. Multi-sensor patient monitor to detect impending cardiac decompensation
US8655004B2 (en) 2007-10-16 2014-02-18 Apple Inc. Sports monitoring system for headphones, earbuds and/or headsets
JP4858400B2 (en) 2007-10-17 2012-01-18 ソニー株式会社 Information providing system, information providing apparatus, and information providing method
US9513699B2 (en) 2007-10-24 2016-12-06 Invention Science Fund I, LL Method of selecting a second content based on a user's reaction to a first content
US20120029369A1 (en) 2007-10-31 2012-02-02 Icove David J Passive Microwave Assessment of Human Body Core to Surface Temperature Gradients and Basal Metabolic Rate
WO2009108228A1 (en) 2008-02-25 2009-09-03 Kingsdown, Inc. Systems and methods for controlling a bedroom environment and for providing sleep data
WO2009134862A2 (en) 2008-04-29 2009-11-05 University Of Miami System and method for using interactive voice-recognition to automate a patient-centered best practice approach to disease evaluation and management
US20090295712A1 (en) 2008-05-29 2009-12-03 Sony Ericsson Mobile Communications Ab Portable projector and method of operating a portable projector
CN102088899B (en) 2008-07-11 2013-03-06 国立大学法人筑波大学 Blood vessel characteristics measurement device and method for measuring blood vessel characteristics
US20100094141A1 (en) 2008-10-14 2010-04-15 Amal Lesly Puswella Jugular venous pressure ruler
US20120123232A1 (en) 2008-12-16 2012-05-17 Kayvan Najarian Method and apparatus for determining heart rate variability using wavelet transformation
US8688467B2 (en) 2009-01-09 2014-04-01 Cerner Innovation, Inc. Automated analysis of data collected by in-vivo devices
US20130035563A1 (en) 2010-01-26 2013-02-07 Angelides Kimon J Progressively Personalized Wireless-Based Interactive Diabetes Treatment
US9526429B2 (en) 2009-02-06 2016-12-27 Resmed Sensor Technologies Limited Apparatus, system and method for chronic disease monitoring
US9498718B2 (en) 2009-05-01 2016-11-22 Microsoft Technology Licensing, Llc Altering a view perspective within a display environment
US8289185B2 (en) 2009-05-05 2012-10-16 Advanced Technologies Group, LLC Sports telemetry system for collecting performance metrics and data
US8856691B2 (en) 2009-05-29 2014-10-07 Microsoft Corporation Gesture tool
US9775529B2 (en) 2009-06-17 2017-10-03 Sotera Wireless, Inc. Body-worn pulse oximeter
US8821350B2 (en) 2009-07-02 2014-09-02 Richard J. Maertz Exercise and communications system and associated methods
US9400548B2 (en) 2009-10-19 2016-07-26 Microsoft Technology Licensing, Llc Gesture personalization and profile roaming
US9832019B2 (en) 2009-11-17 2017-11-28 Unho Choi Authentication in ubiquitous environment
WO2011066343A2 (en) 2009-11-24 2011-06-03 Next Holdings Limited Methods and apparatus for gesture recognition mode control
US20110213218A1 (en) 2009-12-17 2011-09-01 Weiner Bert A Patient healthcare monitoring/maintenance system
US9335825B2 (en) 2010-01-26 2016-05-10 Nokia Technologies Oy Gesture control
US8522308B2 (en) 2010-02-11 2013-08-27 Verizon Patent And Licensing Inc. Systems and methods for providing a spatial-input-based multi-user shared display experience
US20140297006A1 (en) 2010-03-12 2014-10-02 Rajendra Padma Sadhu System and method for providing physiological feedback and rewards for engaging user and retention of customer
JP2011204019A (en) 2010-03-25 2011-10-13 Sony Corp Gesture input device, gesture input method, and program
US9477324B2 (en) 2010-03-29 2016-10-25 Hewlett-Packard Development Company, L.P. Gesture processing
US20110245688A1 (en) 2010-03-31 2011-10-06 General Electric Company System and method of performing electrocardiography with motion detection
US9642536B2 (en) 2010-06-07 2017-05-09 Affectiva, Inc. Mental state analysis using heart rate collection based on video imagery
US8301232B2 (en) 2010-06-08 2012-10-30 Alivecor, Inc. Wireless, ultrasonic personal health monitoring system
US20110307842A1 (en) 2010-06-14 2011-12-15 I-Jen Chiang Electronic reading device
JP2012028015A (en) 2010-07-20 2012-02-09 Toshiba Corp Illumination control system and illumination control method
EP2417908A1 (en) 2010-08-12 2012-02-15 Philips Intellectual Property & Standards GmbH Device, system and method for measuring vital signs
US9075434B2 (en) 2010-08-20 2015-07-07 Microsoft Technology Licensing, Llc Translating user motion into multiple object responses
US8772621B2 (en) 2010-11-09 2014-07-08 Smule, Inc. System and method for capture and rendering of performance on synthetic string instrument
US8475367B1 (en) 2011-01-09 2013-07-02 Fitbit, Inc. Biometric monitoring device having a body weight sensor, and methods of operating same
US9011346B2 (en) * 2011-01-27 2015-04-21 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for monitoring the circulatory system
WO2012112407A1 (en) 2011-02-14 2012-08-23 Chung Wayne Wireless physiological sensor system and method
US9298287B2 (en) 2011-03-31 2016-03-29 Microsoft Technology Licensing, Llc Combined activation for natural user interface systems
US20120280900A1 (en) 2011-05-06 2012-11-08 Nokia Corporation Gesture recognition using plural sensors
US20140139616A1 (en) 2012-01-27 2014-05-22 Intouch Technologies, Inc. Enhanced Diagnostics for a Telepresence Robot
US20120310665A1 (en) 2011-06-01 2012-12-06 Xerox Corporation Personalized medical record
US8179604B1 (en) 2011-07-13 2012-05-15 Google Inc. Wearable marker for passive interaction
US8740793B2 (en) 2011-08-29 2014-06-03 General Electric Company Radar based systems and methods for monitoring a subject
US8617081B2 (en) * 2011-09-28 2013-12-31 Xerox Corporation Estimating cardiac pulse recovery from multi-channel source data via constrained source separation
US9268406B2 (en) 2011-09-30 2016-02-23 Microsoft Technology Licensing, Llc Virtual spectator experience with a personal audio/visual apparatus
CN102660988B (en) 2011-10-18 2014-03-12 北京盈胜泰科技术有限公司 Intelligent toilet
US8869115B2 (en) 2011-11-23 2014-10-21 General Electric Company Systems and methods for emotive software usability
US9557819B2 (en) 2011-11-23 2017-01-31 Intel Corporation Gesture input with multiple views, displays and physics
KR101849373B1 (en) 2012-01-31 2018-04-17 한국전자통신연구원 Apparatus and method for estimating skeleton structure of human body
US9448636B2 (en) 2012-04-18 2016-09-20 Arb Labs Inc. Identifying gestures using gesture data compressed by PCA, principal joint variable analysis, and compressed feature matrices
US20130283203A1 (en) 2012-04-24 2013-10-24 Yahoo! Inc. Method and system for displaying search results
US20140121540A1 (en) 2012-05-09 2014-05-01 Aliphcom System and method for monitoring the health of a user
US8897522B2 (en) 2012-05-30 2014-11-25 Xerox Corporation Processing a video for vascular pattern detection and cardiac function analysis
US9183310B2 (en) 2012-06-12 2015-11-10 Microsoft Technology Licensing, Llc Disambiguating intents within search engine result pages
BR112014030765A2 (en) 2012-06-12 2017-06-27 Koninklijke Philips Nv system for determining an individual's vital sign, device for determining an individual's vital sign, method for determining an individual's vital sign, and computer program
US20130338460A1 (en) 2012-06-18 2013-12-19 David Da He Wearable Device for Continuous Cardiac Monitoring
JP2015532021A (en) 2012-06-19 2015-11-05 ナショナル ユニヴァーシティー オブ シンガポール System and method for remote consultation and condition assessment using parallel data and voice communication paths
US9005129B2 (en) 2012-06-22 2015-04-14 Fitbit, Inc. Wearable heart rate monitor
US9042971B2 (en) 2012-06-22 2015-05-26 Fitbit, Inc. Biometric monitoring device with heart rate measurement activated by a single user-gesture
US8768438B2 (en) 2012-06-25 2014-07-01 Xerox Corporation Determining cardiac arrhythmia from a video of a subject being monitored for cardiac function
US10498623B2 (en) 2012-06-27 2019-12-03 Ubiquiti Inc. Method and apparatus for monitoring and processing sensor data using a sensor-interfacing device
US8819812B1 (en) 2012-08-16 2014-08-26 Amazon Technologies, Inc. Gesture recognition for device input
US20140051941A1 (en) * 2012-08-17 2014-02-20 Rare Light, Inc. Obtaining physiological measurements using a portable device
US9230160B1 (en) 2012-08-27 2016-01-05 Amazon Technologies, Inc. Method, medium, and system for online ordering using sign language
WO2014036436A1 (en) 2012-08-30 2014-03-06 Alivecor, Inc. Cardiac performance monitoring system for use with mobile communications devices
EP2892421A1 (en) 2012-09-04 2015-07-15 Whoop, Inc. Systems, devices and methods for continuous heart rate monitoring and interpretation
US9811901B2 (en) 2012-09-07 2017-11-07 Massachusetts Institute Of Technology Linear-based Eulerian motion modulation
US20140073969A1 (en) 2012-09-12 2014-03-13 Neurosky, Inc. Mobile cardiac health monitoring
US9877650B2 (en) 2012-09-20 2018-01-30 Masimo Corporation Physiological monitor with mobile computing device connectivity
US9002174B2 (en) 2012-10-01 2015-04-07 Microsoft Technology Licensing, Llc Semantic zoom for related content
CN105338890B (en) * 2012-11-11 2018-10-09 肯库有限责任公司 The method and apparatus for determining life parameters
US10551928B2 (en) 2012-11-20 2020-02-04 Samsung Electronics Company, Ltd. GUI transitions on wearable electronic device
US20140191939A1 (en) 2013-01-09 2014-07-10 Microsoft Corporation Using nonverbal communication in determining actions
WO2014107769A1 (en) 2013-01-14 2014-07-17 Uscom Limited Combined blood flow and pressure monitoring system and method
EP2948880A1 (en) 2013-01-25 2015-12-02 Vanderbilt University Smart mobile health monitoring system and related methods
WO2014124520A1 (en) 2013-02-13 2014-08-21 Mespere Lifesciences Inc. Method and device for measuring venous blood oxygenation
IN2013CH00818A (en) 2013-02-25 2015-08-14 Cognizant Technology Solutions India Pvt Ltd
US9203835B2 (en) 2013-03-01 2015-12-01 Paypal, Inc. Systems and methods for authenticating a user based on a biometric model associated with the user
WO2014138280A1 (en) 2013-03-05 2014-09-12 Vtm, Llc Medical telecommunications system
CA2903969A1 (en) 2013-03-06 2014-09-12 Koninklijke Philips N.V. System and method for determining vital sign information
US20140280295A1 (en) 2013-03-14 2014-09-18 Microsoft Corporation Multi-language information retrieval and advertising
WO2014144269A1 (en) 2013-03-15 2014-09-18 Mary Hogue Barrett Managing and accounting for privacy settings through tiered cookie set access
US20140364711A1 (en) 2013-03-27 2014-12-11 AkibaH Health Corporation All-in-one analyte sensor in a detachable external mobile device case
US9971414B2 (en) 2013-04-01 2018-05-15 University Of Washington Through Its Center For Commercialization Devices, systems, and methods for detecting gestures using wireless communication signals
GB201306475D0 (en) 2013-04-10 2013-05-22 Elliptic Laboratories As Touchless interaction devices
US10201278B2 (en) 2013-04-18 2019-02-12 California Institute Of Technology Life detecting radars
US20140357369A1 (en) 2013-06-04 2014-12-04 Microsoft Corporation Group inputs via image sensor system
US20150029050A1 (en) 2013-07-25 2015-01-29 Elwha Llc Wearable radar reflectors
EP3030145B1 (en) * 2013-08-07 2018-05-30 Koninklijke Philips N.V. Monitoring system and method for monitoring the hemodynamic status of a subject
US20150046183A1 (en) 2013-08-12 2015-02-12 James V. Cireddu Remote, virtual physical exam acquisition and distribution
FI126008B (en) 2013-09-13 2016-05-31 Murata Manufacturing Co Cardiac monitoring system
CN104434078A (en) * 2013-09-13 2015-03-25 施乐公司 System and method for determining video-based pulse transit time with time-series signals
US9383426B2 (en) 2013-09-17 2016-07-05 Farrokh Mohamadi Real-time, two dimensional (2-D) tracking of first responders with identification inside premises
US20150085060A1 (en) 2013-09-20 2015-03-26 Microsoft Corporation User experience for conferencing with a touch screen display
US10152761B2 (en) 2013-10-04 2018-12-11 Iqvia Inc. Facilitating transactions for health applications designed for mobile devices
US20150112156A1 (en) * 2013-10-23 2015-04-23 Quanttus, Inc. Predicting medical events
US9594443B2 (en) 2014-02-26 2017-03-14 Lenovo (Singapore) Pte. Ltd. Wearable device authentication and operation
US20150257653A1 (en) * 2014-03-14 2015-09-17 Elwha Llc Device, system, and method for determining blood pressure in a mammalian subject
US9921657B2 (en) 2014-03-28 2018-03-20 Intel Corporation Radar-based gesture recognition
US9575560B2 (en) 2014-06-03 2017-02-21 Google Inc. Radar-based gesture-recognition through a wearable device
GB2528044B (en) 2014-07-04 2018-08-22 Arc Devices Ni Ltd Non-touch optical detection of vital signs
US9921660B2 (en) 2014-08-07 2018-03-20 Google Llc Radar-based gesture recognition
US9811164B2 (en) 2014-08-07 2017-11-07 Google Inc. Radar-based gesture sensing and data transmission
US20160054792A1 (en) 2014-08-22 2016-02-25 Google Inc. Radar-Based Biometric Recognition
US9778749B2 (en) 2014-08-22 2017-10-03 Google Inc. Occluded gesture recognition
US11169988B2 (en) 2014-08-22 2021-11-09 Google Llc Radar recognition-aided search
US9600080B2 (en) 2014-10-02 2017-03-21 Google Inc. Non-line-of-sight radar-based gesture recognition
GB201417536D0 (en) 2014-10-03 2014-11-19 Microsoft Corp Adapting quantization
US20160106328A1 (en) * 2014-10-16 2016-04-21 Xerox Corporation Determining arterial pulse transit time from time-series signals obtained at proximal and distal arterial sites
CN104398246B (en) * 2014-12-17 2016-07-27 电子科技大学 A kind of finger ring type chip based on flexible sensor detection human blood-pressure
US10064582B2 (en) 2015-01-19 2018-09-04 Google Llc Noninvasive determination of cardiac health and other functional states and trends for human physiological systems
KR101560282B1 (en) 2015-03-06 2015-10-14 주식회사 휴이노 Mobile device having functions of measuring bio-signals and realtime-monitoring blood pressure estimation based on measured bio-signals
US9848780B1 (en) 2015-04-08 2017-12-26 Google Inc. Assessing cardiovascular function using an optical sensor
US20160321428A1 (en) 2015-04-29 2016-11-03 Google, Inc. Customizable Health Monitoring
US20160338599A1 (en) 2015-05-22 2016-11-24 Google, Inc. Synchronizing Cardiovascular Sensors for Cardiovascular Monitoring
US20180296163A1 (en) 2015-07-27 2018-10-18 Google Inc. Altering Physiological Signals Based On Patient Movement

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030036685A1 (en) * 2000-04-27 2003-02-20 Vitalsines International, Inc. Physiological signal monitoring system
US20080039731A1 (en) * 2005-08-22 2008-02-14 Massachusetts Institute Of Technology Wearable Pulse Wave Velocity Blood Pressure Sensor and Methods of Calibration Thereof
US20090299197A1 (en) * 2008-06-02 2009-12-03 Antonelli Lynn T Remote Blood Pressure Waveform Sensing Method and Apparatus
US20160045706A1 (en) * 2013-04-10 2016-02-18 Koninklijke Philips N.V. System and method for enhancing sleep slow wave activity based on cardiac activity
US20160089042A1 (en) * 2014-09-29 2016-03-31 Microsoft Corporation Wearable pulse pressure wave sensing device

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10948996B2 (en) 2014-06-03 2021-03-16 Google Llc Radar-based gesture-recognition at a surface of an object
US10642367B2 (en) 2014-08-07 2020-05-05 Google Llc Radar-based gesture sensing and data transmission
US11221682B2 (en) 2014-08-22 2022-01-11 Google Llc Occluded gesture recognition
US11169988B2 (en) 2014-08-22 2021-11-09 Google Llc Radar recognition-aided search
US10936081B2 (en) 2014-08-22 2021-03-02 Google Llc Occluded gesture recognition
US11816101B2 (en) 2014-08-22 2023-11-14 Google Llc Radar recognition-aided search
US10409385B2 (en) 2014-08-22 2019-09-10 Google Llc Occluded gesture recognition
US10664059B2 (en) 2014-10-02 2020-05-26 Google Llc Non-line-of-sight radar-based gesture recognition
US11163371B2 (en) 2014-10-02 2021-11-02 Google Llc Non-line-of-sight radar-based gesture recognition
US10064582B2 (en) 2015-01-19 2018-09-04 Google Llc Noninvasive determination of cardiac health and other functional states and trends for human physiological systems
US11219412B2 (en) 2015-03-23 2022-01-11 Google Llc In-ear health monitoring
US10016162B1 (en) 2015-03-23 2018-07-10 Google Llc In-ear health monitoring
US10496182B2 (en) 2015-04-30 2019-12-03 Google Llc Type-agnostic RF signal representations
US11709552B2 (en) 2015-04-30 2023-07-25 Google Llc RF-based micro-motion tracking for gesture tracking and recognition
US10664061B2 (en) 2015-04-30 2020-05-26 Google Llc Wide-field radar-based gesture recognition
US10817070B2 (en) 2015-04-30 2020-10-27 Google Llc RF-based micro-motion tracking for gesture tracking and recognition
US10080528B2 (en) 2015-05-19 2018-09-25 Google Llc Optical central venous pressure measurement
US10936085B2 (en) 2015-05-27 2021-03-02 Google Llc Gesture detection and interactions
US10376195B1 (en) 2015-06-04 2019-08-13 Google Llc Automated nursing assessment
US10503883B1 (en) 2015-10-06 2019-12-10 Google Llc Radar-based authentication
US11256335B2 (en) 2015-10-06 2022-02-22 Google Llc Fine-motion virtual-reality or augmented-reality control using radar
US10823841B1 (en) 2015-10-06 2020-11-03 Google Llc Radar imaging on a mobile computing device
US10768712B2 (en) 2015-10-06 2020-09-08 Google Llc Gesture component with gesture library
US11132065B2 (en) 2015-10-06 2021-09-28 Google Llc Radar-enabled sensor fusion
US12085670B2 (en) 2015-10-06 2024-09-10 Google Llc Advanced gaming and virtual reality control using radar
US10705185B1 (en) 2015-10-06 2020-07-07 Google Llc Application-based signal processing parameters in radar-based detection
US10540001B1 (en) 2015-10-06 2020-01-21 Google Llc Fine-motion virtual-reality or augmented-reality control using radar
US11175743B2 (en) 2015-10-06 2021-11-16 Google Llc Gesture recognition using multiple antenna
US10459080B1 (en) 2015-10-06 2019-10-29 Google Llc Radar-based object detection for vehicles
US10401490B2 (en) 2015-10-06 2019-09-03 Google Llc Radar-enabled sensor fusion
US10908696B2 (en) 2015-10-06 2021-02-02 Google Llc Advanced gaming and virtual reality control using radar
US11385721B2 (en) 2015-10-06 2022-07-12 Google Llc Application-based signal processing parameters in radar-based detection
US11481040B2 (en) 2015-10-06 2022-10-25 Google Llc User-customizable machine-learning in radar-based gesture detection
US11592909B2 (en) 2015-10-06 2023-02-28 Google Llc Fine-motion virtual-reality or augmented-reality control using radar
US11656336B2 (en) 2015-10-06 2023-05-23 Google Llc Advanced gaming and virtual reality control using radar
US11693092B2 (en) 2015-10-06 2023-07-04 Google Llc Gesture recognition using multiple antenna
US11698438B2 (en) 2015-10-06 2023-07-11 Google Llc Gesture recognition using multiple antenna
US11698439B2 (en) 2015-10-06 2023-07-11 Google Llc Gesture recognition using multiple antenna
US10379621B2 (en) 2015-10-06 2019-08-13 Google Llc Gesture component with gesture library
US10310621B1 (en) 2015-10-06 2019-06-04 Google Llc Radar gesture sensing using existing data protocols
US11140787B2 (en) 2016-05-03 2021-10-05 Google Llc Connecting an electronic component to an interactive textile

Also Published As

Publication number Publication date
EP3280324A1 (en) 2018-02-14
US9848780B1 (en) 2017-12-26
EP3280324A4 (en) 2018-12-12
US20180000354A1 (en) 2018-01-04
CN107427237A (en) 2017-12-01
CN107427237B (en) 2020-06-05
WO2016178797A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
US9848780B1 (en) Assessing cardiovascular function using an optical sensor
US20160338599A1 (en) Synchronizing Cardiovascular Sensors for Cardiovascular Monitoring
US20180296163A1 (en) Altering Physiological Signals Based On Patient Movement
US10064582B2 (en) Noninvasive determination of cardiac health and other functional states and trends for human physiological systems
JP6688877B2 (en) Device and system for monitoring heartbeat related information of a subject
US10080528B2 (en) Optical central venous pressure measurement
JP6615176B2 (en) Non-interfering skin tissue hydration measuring device and related method
US20160106327A1 (en) Apparatus and method for acquiring bio-information
JP5883018B2 (en) Apparatus, system, and method for measuring blood pressure within at least one blood vessel
Poh et al. Validation of a standalone smartphone application for measuring heart rate using imaging photoplethysmography
JP2017534378A (en) Method, system, and computer program product for determining hemodynamic parameters using signals obtained by multispectral imaging of blood flow and perfusion
US11517223B2 (en) Apparatus and method for estimating blood glucose
Allen et al. Photoplethysmography (PPG): state-of-the-art methods and applications
Steinman et al. Smartphones and video cameras: future methods for blood pressure measurement
WO2021084488A1 (en) Smartglasses for detecting physiological parameters
US20240016401A1 (en) Systems and methods for analysis of pulse and physiological, pathological, and emotional state and applications thereof
JP7293506B2 (en) Methods and systems for determining cardiovascular parameters
CN108430317A (en) Method and device for the hemodynamic blood pressure of calculating optical
TWI836529B (en) Method for estimating blood pressures by using photoplethysmography signal analysis and system
Nowara et al. Seeing beneath the skin with computational photography
Patil et al. MobiEye: turning your smartphones into a ubiquitous unobtrusive vital sign monitoring system
van Putten et al. Improving systolic blood pressure prediction from remote photoplethysmography using a stacked ensemble regressor
van Putten et al. From video to vital signs: using personal device cameras to measure pulse rate and predict blood pressure using explainable AI
Guo et al. OfficeBP: noninvasive continuous blood pressure monitoring based on PPT in office environment
WO2024153587A1 (en) Arrangement for determining a pulse wave transit time of an object, computer-implemented method and computer program product

Legal Events

Date Code Title Description
AS Assignment

Owner name: GOOGLE INC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DEBUSSCHERE, BRIAN DEREK;ROGERS, JEFFREY L.;REEL/FRAME:043683/0509

Effective date: 20150407

AS Assignment

Owner name: GOOGLE LLC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:GOOGLE INC.;REEL/FRAME:044567/0001

Effective date: 20170929

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION